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Chapter 1 
Introduction 
Endometriosis can be defined as the presence of histologically and functionally 
endometrial-like tissue in areas other than the uterine mucosa, predominantly 
occurring in the pelvic region. Although the term "endometriosis" was first coined 
by Sampson in 1921 [1], it was allready described in several earlier reports under 
different names like adenomyoma, fibroadenomatosus seroepithelialis, and 
heterotopen Epithelwucherung [2,3]. The first accurate description of 
endometriosis is credited to Rokitansky in 1860 [3]. 
Endometriosis has been separated into the occurrence of endometrial-like 
tissue within the myometrium (endometriosis interna) or beyond the uterine 
mucosa (endometriosis externa). Both types of endometriosis appear to be 
separate pathologic entities [4]. At present endometriosis interna is called 
adenomyosis which will not be considered further. 
Complaints related to endometriosis are those of dysmenorrhoea, dyspareunia, 
and pelvic pain. Especially in women undergoing laparoscopy as part of an 
infertility investigation, endometriosis is frequently observed [5,6]. Therefore, 
endometriosis is also associated with infertility, although a causal relationship has 
not been proven yet. The prevalence of endometriosis has been estimated in 
different diagnostic groups of patients from below 1% to as high as 72% [7,8]. 
However, endometriosis can also be asymptomatic, and women with 
endometriosis can conceive without treatment. To estimate the prevalence of 
endometriosis in asymptomatic, fertile women, most studies examined women 
undergoing tubal ligation [6,9-11]. Estimates as to the prevalence of 
endometriosis in these women vary from 1% to 43%. Several factors may attribute 
to this wide range. These women often use oral contraceptives which may inhibit 
or suppress endometriosis. Only one (retrospective) study excluded women using 
oral contraceptives [6]. In retrospective studies endometriosis estimates may be 
rather low, because it is known that normally less efforts are made to visualize 
the pelvic peritoneum during laparoscopy for tubal ligation. Liu and Hitchcock 
[10] performed the laparoscopy during menstruation. Their comparatively high 
prevalence of endometriosis (43%, all mild stages) in asymptomatic, fertile women 
was explained in part by the fact that mild stages of endometriosis may be 
detected more readily during menstruation. It can be concluded that, although 
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endometriosis is frequently diagnosed at laparoscopy, in most cases it remains 
uncertain whether it is indeed responsible for the complaints for which 
laparoscopy was indicated. 
In this chapter, the literature is reviewed on the histo- and pathogenesis of 
endometriosis, current methods for diagnosis and classification, and the 
supposed association with infertility. This thesis investigates in particular 
retrograde seeding of endometrial cells and the interaction of these cells with 
peritoneal fluid (PF). Therefore, retrograde menstruation and its possible 
consequences for the development of endometriosis and infertility will be 
reviewed more comprehensively. 
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Histogenesis and pathogenesis of endometriosis 
Coelomic metaplasia versus endometrial Implantation theory 
A variety of theories regarding the histogenesis of endometriosis have been 
presented. They can be divided in three main alternatives as shown in Table 1.1. 
In the earliest theories, endometriosis is thought to originate from either 
remnant cells from the Müllerian ducts [3,12] or the Wolffian ducts [3], or from 
metaplasia of the peritoneal and ovarian epithelium [2,3,13,14]. Because 
endometriosis is a disease restricted to women during their reproductive years, 
ovarian hormonal activity appears to be a prerequisite [2,3,13,14]. In men the 
development of endometriosis has only been described after the use of high 
doses of estrogens [15,16]. In the presence of ovarian hormonal activity, 
inflammation has been suggested to trigger the initiation of this coelomic 
metaplasia [2,3,13,14]. 
Based on elaborative previous studies [1,17-19], Sampson introduced the 
endometrial implantation theory in 1927 [20,21]. This theory was based on 
observations of both blood escaping from the fallopian tubes in women operated 
Table 1.1. Theories on the histogenesis of endometriosis, modified from Ridley [3]. 
I. in situ development 
germinal epithelium of the ovary (Waldeyer, 1870) 
embryonic cell rests 
- Wolffian ducts (Von Recklinghausen, 1895) 
- Müllerian ducts (Rüssel, 1899; Culten, 1914) 
coelomic metaplasia (Iwanoff, 1898; Meyer, 1903) 
omnipotent blastema (induction theory) (Levander, 1941) 
secondary Müllerian system (Lauchlan, 1972) 
II. endometrial implantation theory (Sampson, 1927) 
III. combination of in situ development and endometrial implantation 
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during menstruation, and endometrial tissue fragments occasionally present in the 
tubal lumina. Sampson suggested that retrograde flow of endometrial cells 
through the fallopian tubes during menstruation can lead to implantation of these 
cells upon the ovaries and other peritoneal sites, ultimately resulting in 
endometriosis. His theory was questioned because retrograde menstruation was 
thought to be a rare phenomenon [22], and menstrual discharge was believed to 
consist of necrotic material only [14,22]. 
The viability of endometrial cells in antegrade menstrual discharge was proven 
by Keettel and Stein [23]. They cultured tissue fragments of human endometrium 
obtained from antegrade menstrual discharge and showed the presence of 
adhering and proliferating cells which were either fibroblastic or epithelioid in 
appearance. Ridley and Edwards [24] injected the cell fraction of menstrual fluid 
obtained from the vagina into the abdominal wall superficial to the fascia of 
women prior to laparotomy (90 to 180 days later). They observed the 
development of endometriosis at the sites of injection in a minority of these 
women. These studies however are not conclusive for the theory that retrograde 
menstruation can result in endometriosis as a consequence of endometrial 
implantation. 
With regard to the occurrence of retrograde menstruation in humans, Polishuk 
and Sharf [25], performing culdoscopy during the menstrual period, found blood 
stained PF in 50% of the patients. Blumenkrantz ei a/. [26] observed the 
occurrence of blood contaminated dialysate in 9 out of 11 patients undergoing 
peritoneal dialysis during their menstrual period. Only recently, a systematic study 
of Halme et al. [27] indicated that retrograde menstruation is a common and 
physiologic event in menstruating women with patent tubes. This was confirmed 
by Uu and Hitchkock [10]. 
The anatomic distribution of endometriosis supports the concept of retrograde 
menstruation being a significant factor in the pathogenesis of endometriosis. 
Endometriotic foci are mainly located in the pelvic region of the peritoneal cavity, 
at sites where refluxed menstrual fluid sediments as governed by the effects of 
gravity [28]. In addition, endometriosis appears to be correlated with short cycle 
lenghts and a longer duration of menstruation, resulting in a more extended intra-
abdominal menstrual contamination [29]. 
Studies analyzing the presence of endometrial cells in PF as a consequence 
of retrograde menstruation are conflicting, the incidence varying from 0% to 59% 
[26,30-35]. This wide variation can be attributed to methodological differences in 
identifying endometrial cells in PF, and to the fact that PF samples were obtained 
during various stages of the menstrual cycle. All reports identifying endometrial 
tissue in PF, used cytological and/or cell block analyses [30,31,33]. Although 
12 
viable cells can indeed be recognized by cytology, this does not prove that these 
cells have retained the capacity to adhere and proliferate. Koninckx et el. [30] 
found endometrial tissue most frequently during the follicular phase, the incidence 
decreasing progressively during the luteal phase. The fact that they even 
identified endometrial tissue in PF obtained during the luteal phase both in 
women with and without macroscopic endometriosis, supports the concept that at 
least these endometrial cells are unable to implant since otherwise implantation 
should already have occurred. By culturing the cell pellet of PF, Willemsen ei a/. 
[32] could not identify adhering and proliferating endometrial cells in any of 115 
PF samples obtained during the late follicular phase. So far, no study has 
focused on the early follicular phase using the culture technique to identify active 
endometrial cells in PF, i.e. cells with the capacity to adhere and proliferate. 
Other routes by which endometrial cells may disseminate are lymphogenic 
[36], hematogenic [37], and iatrogenic [17,18,32-35,38,39]. Javert [40] introduced 
the composite theory which includes all the above mentioned routes of 
dissemination of endometrial cells. Examples of iatrogenic disseminated 
endometrial cells are the observation of endometriotic foci in surgical scars after 
uterine operations [17,18] and in Bartholin glands following excision of an 
abscess [38]. This viability of endometrial tissue has been used to transplant it 
into the vault of the vagina at the time of hysterectomy in order to retain 
menstruations [41]. An iatrogenic contribution to the development of 
endometriosis by means of uterine-tubal flushing for tubal patency testing has 
been suggested by several authors who demonstrated the presence of 
endometrial glandular tissue fragments and endometrial cells in PF following 
flushing of uterus and fallopian tubes [32,35,39]. 
Levander introduced the induction theory, according to which specific 
substances liberated from degenerating endometrial tissue induce the 
development of endometrial-like tissue out of the "omnipotent blastema" present in 
connective tissue [42,43]. His theory was based on experiments with rabbits in 
which both fresh and denaturated endometrial tissue was transplanted 
subcutaneously. Endometrial-like epithelium developed at the sites of the implants, 
the development of which was much more pronounced when the transplanted 
piece of endometrial tissue was initially denaturated. The formation of endometrial 
stromal tissue was not described. Merrill [44] implanted filters containing 
endometrial tissue beneath the mesothelium of rabbits and observed the 
formation of glandular structures in the tissue adjacent to the filters. These 
inductive substances may be of stromal origin. Experiments with mice have 
indicated that regional differentiation of Mullerian epithelium during morphogenesis 
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is due to inductive activities of the underlying stromal cells [45]. Lauchlan [46] 
postulated the existence of a secondary Müllerian system being composed of 
cells similar to or identical with those lining the oviducts, uterus and endocervix, 
which are located external to the cavities of the original Müllerian ducts. 
Metaplasia of these cells may result in serous (tubal), endometrial, mucinous 
(endocervical) and Brenner epithelium. In support of this theory he described the 
presence of both serous and mucinous epithelium in foci of endometriosis [46]. 
Kerner et al. [47] showed the presence of unusual ovarian mesothelial inclusions 
in 10% of ovarian endometriosis. They suggested a common stimulus responsible 
for the development of both conditions from the multipotent pelvic peritoneum. 
In summary, during the first half of this century the coelomic metaplasia theory 
was accepted by the majority of authors as the most plausible theory with regard 
to the histogenesis of endometriosis. After it was proven that (antegrade) 
menstrual discharge contains endometrial-like cells with the capacity to adhere 
and proliferate, the endometrial implantation theory became widely accepted as 
the main mechanism for the development of endometriosis. However, no definitive 
proof for this theory has been presented so far. Viable endometrial cells are 
present in PF of both women with and without macroscopic endometriosis. The 
fact that viable endometrial cells have been identified in PF even during the luteal 
phase indicates that at least these endometrial cells are unable to implant. 
Furthermore, arguments introduced in the literature to favour the involvement of 
retrograde menstruation as a significant factor in the pathogenesis of 
endometriosis, can also be interpreted as support for the induction theory. At 
present, the development of endometriosis in situ both from remnant cells from 
the Müllerian ducts [48,49] and from metaplasia of coelomic epithelium [50] still 
find support in the literature. 
(For a more detailed review see: Ridley [3]) 
Etiologic factors 
Retrograde menstruation occurs in the majority of women with patent tubes 
[27], but does not result in macroscopic visible endometriosis in all these women. 
Therefore, additional factors seem necessary for the development of 
endometriosis which can also account for the interindividual differences in severity 
of this disease. Besides the fact that a polygenic / multifactorial inheritance has 
been described in women with endometriosis [51,52], several predisposing 
factors have been suggested. 
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"Luteinized Unruptured Follicle' (LUF) syndrome 
Brosens ef a/. [53] found that the incidence of LUF-cycles in women with 
endometriosis was 79%, whereas in infertile controls with a male and/or tubal 
infertility factor, the incidence was only 6%. Because high concentrations of 
oestradiol-17/J (Ег) and progesterone (P) have been found in PF after ovulation 
[54], it was suggested that these alterations in Е
г
 and Ρ levels in PF around the 
time of ovulation prevent the development of endometriosis [30]. In women with 
LUF, concentrations of both ^ and Ρ are only sligthly elevated during the early 
luteal phase, therefore being a favourable hormonal environment for the 
implantation of refluxed endometrial cells. In contrast to Brosens et al. [53], 
Dmowski ef al. [55] found no difference in incidence of LUF-cycles between 
infertile women with and without endometriosis. In these studies the diagnosis 
LUF was based on laparoscopic findings (absence of an ovulation stigma). In 
fertile women conflicting results have also been reported, the incidence of LUF at 
laparoscopy varying from 9% to 55% [56]. Laparoscopic assessment of the 
ovaries to detect an ovulation stigma appears to be a rather unreliable procedure 
which, among other things, depends on the experience of the laparoscopist, the 
ability to manipulate ovaries, and the time in the menstrual cycle at which 
laparoscopy is performed [55,57-60]. 
An adjunct in the diagnosis of LUF could be the measurement of E2 and Ρ in 
PF, because raised concentrations of these hormones are found after ovulation 
[54,61,62]. However, authors differ in their assessment of the value of these 
changes in PF E2 and Ρ levels for the retrospective diagnosis of ovulation or the 
occurrence of LUF [30,63-66]. Again, a basic deficiency in all these studies is that 
the criterion of ovulation, if determined at all, was an ovulation stigma seen at 
laparoscopy, which in itself has been demonstrated to be inaccurate [55,57-60]. 
After the introduction of ultrasound in the detection of follicular growth and 
ovulation [67-69], this diagnostic tool has also been used in diagnosing LUF [70-
81]. In general, the incidence of LUF in the different patient populations is lower 
when detected by ultrasound (Table 1.2), than when established from 
laparoscopic findings and steroid hormone concentrations in PF [56]. Only 
Liukkonen et al. [73] found a comparatively high incidence of LUF in both women 
with endometriosis (71%) and women with unexplained infertility (65%). They 
performed daily ultrasound scans, and defined LUF cycles as luteinization 
(intrafollicular echoes) of the follicle without follicular collapse. Janssen-Caspers ef 
al. [78] have indicated that within 24 hours after ovulation the development of a 
corpus luteum can occur with a diameter similar in size to the pre-ovulatory 
follicle and hence ovulation (follicular collapse) can be missed. Furthermore, LUF 
cycles appear to have a characteristic follicular growth pattern. Following the LH 
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Table f.2. Diagnosis of LUF by ultrasound in normal cyclic women. 
diagnostic group author 
Paulson et al. [74] 
Janssen-Caspers et al. [78] 
Killick et al. [79] 
Tummon et al. [80] 
Scheenjes [81] 
Kerin et al. [71] 
Paulson et al. [74] 
Tummon et al. [80] 
Kerin et al. [71] 
Liukkonen et al. [73] 
Daly et al. [75] 
Janssen-Caspers et al. 
Tummon et al. [80] 
Scheenjes [81] 
Kerin et al. [71] 
Liukkonen et al. [73] 
Thomas et al. [77] 
4 
[78] 
Janssen-Caspers et al. [78] 
Tummon et al. [80] 
No. Of 
cycles 
studied 
21 
9 
10 
8 
10 
170 
24 
7 
14 
90 
33 
13 
11 
24 
12 
7 
12 
5 
17 
Cycles with LUF 
No. 
0 
1 
2 
0 
0 
9 
0 
0 
1 
57 
3 
0 
1 
5 
0 
5 
2 
1 
1 
% 
0 
11 
20 
0 
0 
5 
0 
0 
7 
63 
9 
0 
9 
20 
0 
71 
17 
20 
6 
fertile, no endometriosis 
infertile, tubal or male factor 
unexplained infertility 
infertile, with endometriosis 
peak, a rapid increase in follicle diameter occurs exceeding 30 mm [72,76,78]. 
Therefore, the reported LUF incidence by Liukkonen et al. [73] probably includes 
cases in which a follicle-like luteal structure occurred within 24 hours after 
ovulation. This is also in agreement with their laparoscopic observations, in which 
a corpus haemorrhagicum was observed in two women with LUF according to 
their ultrasound definition. 
In conclusion, although the diagnosis of LUF remains difficult, the incidence of 
LUF cycles in women with endometriosis at least appears to be less frequently 
than was believed in initial studies. 
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(For more detailed reviews see: Katz [56] and Scheenjes [81]). 
Alterations in the Immune system 
Several alterations in the cellular and humoral immune system of women with 
endometriosis have been reported. Most of these alterations can be interpreted 
as the result of endometriosis rather than being responsible for the development 
of endometriosis. 
Dmowski ef al. [82] studied functional differences in the cell-mediated immune 
response by means of in vitro and in vivo techniques in rhesus monkeys. In 
monkeys with spontaneous endometriosis they observed a decrease in the T-
lymphocyte-mediated immune response to autologous endometrial antigens but 
not to peritoneal antigens. Comparable results were obtained in women with 
endometriosis using in vitro techniques [83]. It was concluded that under normal 
circumstances cellular mechanisms are operative In limiting ectopic growth of 
refluxed endometrial tissue. In women with endometriosis these cellular 
mechanisms are impaired, the degree of impairment being directly related to the 
severity of endometriosis [82-84]. 
Anti-endometrial auto-antibodies have been identified in serum and PF of 
infertile women with endometriosis [85-89], which is consistent with the 
observation of antibody / complement deposits in endometrial tissue of these 
women [85,90-93]. 
Differences in nonspecific immunoglobulin and complement concentrations 
both in serum and PF have been reported between women with and without 
endometriosis, although these reports disagreed with regard to which 
immunoglobulin type (IgA, IgG, or IgM) and/or complement (C3 and C4) was 
elevated or decreased [31,88,90,94-96]. Auto-antibodies in women with 
endometriosis may be present as immune complexes rather than as free 
antibodies, and as such may interfere with the assays used presently. Badawy et 
al. [97] evaluated the capacity of B-lymphocytes to produce immunoglobulins in 
pokeweed mitogen-stimulated cultures. Both IgG and IgA were significantly 
increased in the supernatants of B-cells obtained from both PF and serum of 
infertile women with endometriosis compared to infertile controls. They suggested 
that presensitization of lymphocytes by antigenic products of endometriosis 
renders these cells to be more responsive to the mitogenic effect. 
Studies investigating numerical differences in serum leucocyte profiles are also 
conflicting [97-100]. However, observations in peripheral blood do not necessarily 
reflect the local immune status [98]. More consistent changes in lymphocyte 
subsets have been observed in endometriosis-related PF [97,99,100]. Badawy ei 
al. [97,100] found an increased concentration of T- and B-lymphocytes and an 
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increased ratio of helper T- / suppressor T-lymphocyte subsets in PF of infertile 
women with endometriosis. Hill ef al. [99] confirmed the observation of an 
increased concentration of helper T-lymphocytes in PF. However, they did not 
find a difference in B-lymphocytes and plasma cells. 
Various factors may attribute to these controversial results. Studies differ in the 
composition of a control group, using fertile and infertile women separately or 
combined. Women undergoing laparoscopic sterilization were mostly used as 
fertile controls. The use of oral contraceptives by these women may diminish the 
amount of retrograde menstruation and the activity of endometriosis, and 
therefore interfere with the results. When infertile women were included as 
controls, this group was often ill-defined, including women with different infertility-
related factors. Furthermore, studies were performed during different phases of 
the menstrual cycle. 
Macrophages play an essential role in the immune system. Elevated numbers 
and concentrations of peritoneal macrophages (PM) have been found in PF of 
women with endometriosis as compared to controls [31,101-107], although this 
was not confirmed by others [103,108,109]. Halme et al. [103] suggested that 
even though PM numbers are not consistently elevated in women with 
endometriosis, a qualitative difference in the activity of PM may be present in this 
disease. They investigated the activity of PM using immuno-cytochemical and 
flow-cytofluorometric analyses for the enzymes myeloperoxidase, acid 
phosphatase and leucine aminopeptidase [108,110]. Staining for myeloperoxidase 
is indicative for recently arrived, monocyte-like PM, whereas staining for acid 
phosphatase and leucine aminopeptidase indicates activated and differentiated 
PM. It was shown that activation and differentiation of PM during the menstrual 
cycle is much more pronounced in infertile women with endometriosis, as 
indicated by a higher percentage of PM staining with acid phosphatase and 
leucine aminopeptidase. These observations were later confirmed by Chacho ef 
a/. [104]. Dunselman ef al. [107] found increased phagocytosis of sheep red 
blood cells by PM of women with endometriosis, which is consistent with an 
advanced stage of differentiation. However, they also observed a decreased 
production of highly reactive intermediate products of oxygen reduction, being a 
parameter for intracellular killing. This dissociation between increased 
phagocytosis and decreased killing potential was explained by the stepwise 
fashion of differentiation of macrophages. 
Activated macrophages release a number of biologically active products, 
known as monokines. Such products include interleukin-1 (IL-1) and tumor 
necrosis factor (TNF) which are important mediators of the immune response. 
Conflicting data are reported with regard to PF IL-1 concentrations in women with 
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endometriosis. Fakih et al. [111] observed significantly more IL-1 activity in PF of 
women with mild endometriosis compared to fertile controls. Awadalla et al. [109] 
did not find a difference in mean IL-1 activity when compared to infertile controls. 
Hill ef al. [112] demonstrated that PF of women with endometriosis ¡s 
immunostlmulatory. Endometriosis-related PF samples significantly enhanced 
lymphocyte proliferation in vitro compared to fertile controls, especially in mitogen-
stimulated cultures which stimulates macrophage-dependent T-lymphocyte 
proliferation, lnterleukin-1 is known to stimulate T-lymphocyte proliferation. 
However, an elevated IL-1 activity was found in only a minority of infertile women 
with endometriosis, but in none of fertile controls and women with unexplained 
Infertility. They speculated that other macrophage-dependent T-lymphocyte growth 
promotors, that are currently uncharacterized, may be responsible for this 
enhanced lymphocyte proliferation. Besides the fact that these studies used 
different control groups, they also used different assay methods for determining 
IL-1 activity (radioimmuno- or bio-assay) which can explain differences in results. 
Elevated concentrations of TNF have also been found in endometriosis-related PF 
samples [113,114]. 
With regard to the data indicating that PM are more differentiated and 
activated In women with endometriosis, Halme eí al. [105] described an 
alternative mechanism for the development of endometriosis (Figure 1.1). They 
suggested that under normal circumstances the maturation of PM is limited. In 
women with endometriosis the mechanism responsible for this limitation is 
diminished, resulting in more mature PM as indicated by a higher proportion of 
large macrophages with increased expression of antigen markers and an 
increased cell membrane capping function. These PM release growth-promoting 
substances that may facilitate implantation and proliferation of retrogradely 
seeded endometrial cells [115,116]. 
The fact that most reports used heterogeneous control groups when studying 
possible alterations in the peritoneal environment in infertile women with 
endometriosis, prompted Olive ef al. [117] to delineate more precisely those 
factors that are associated with elevated numbers of PM. Using multiple 
regression analysis they found the best correlation in women with infertility and 
no mechanical infertility factors (all women studied had a ovulatory cycle and 
infertile couples with a male factor and poor postcoital tests were excluded). The 
total amount of lysozyme in PF, being a major secretory product of 
macrophages, was also highest in the group of infertile women without 
mechanical infertility factors [118]. Serum lysozyme levels were In the normal 
range and did not correlate with the total amount of lysozyme In PF, indicating 
that the macrophage activity was confined to the peritoneal cavity. Previous 
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Figure 1.1. Hypothesis regarding pathophysiologic characteristics of human peritoneal 
macrophages (PM) in endometriosis. The presence of higher numbers and larger, 
more mature PM in endometriosis may lead to secretion of putative growth factors 
facilitating implantation and growth of endometrial cells (from Halme et al. [105], 
with permission). 
studies had already demonstrated that retrograde menstruation influenced the 
number and differentiation grade of PM [102,103,110]. Therefore, Olive et al. 
[117,118] stated that it may well be that intraperitoneal inflammation and 
leucocytosis is a response by some women to the process (retrograde 
menstruation), rather than the occasional consequence of that process 
(endometriosis implants). In support of this theory, it has been reported that 
medical treatment (medroxyprogesterone-acetate) of women with endometriosis 
for 4 months, during which no menstruations occur, results in a significant 
reduction of PF volume and number of PM [119]. However, it has to be noted 
that these changes may also be the result of the suppressed ovarian and 
endometriotic activity during medical treatment. 
Retrograde menstruation has also been associated with other auto-immune 
diseases. Grimes et al. [120] investigated the relation between systemic lupus 
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erythematosus (SLE) and reproductive function, since SLE characteristically afflicts 
women of reproductive age. In a case-control study, they found that prior 
hysterectomy or tubal sterilization had a significant protective effect, whereas 
endometriosis was associated with a two-fold increased risk of SLE, although this 
increase was not significant. Their conclusion was that retrograde menstruation 
may be an inciting factor for SLE in susceptible women. 
In conclusion, it is obvious that the immune system is altered in women with 
macroscopic endometriosis. However, it remains to be established, whether a 
causal relationship exists between endometriosis and these changes in the 
immune system. Both conditions can also be mediated by other processes which 
may include retrograde menstruation. When indeed some changes in the 
immune system are directly associated with the presence of endometriosis, it 
remains possible that these alterations simply reflect chronic exposure to 
endometriotic lesions instead of being a predisposing factor for the development 
of these lesions. 
Mechanical factors related to the amount of retrograde menstruation 
Scott ef a/. [121] inverted the uterus in rhesus monkeys so that "antegrade" 
menstruation occurred into the pelvis. It was shown that exposure of the pelvis to 
increased amounts of menstrual discharge more frequently results in the 
development of endometriosis. In humans, uterine outflow obstructions resulting in 
more extended intra-abdominal menstrual contamination, have also been 
associated with endometriosis [38,122-125]. Hughesdon [123] reviewed the 
literature of gross retrograde menstruation due to genital tract obstructions and 
suggested that the presence or absence of endometriosis in these women 
depends on the period during which the greater menstrual reflux occurs (critical 
interval from 1 to 3 years). He proposed four possible reasons for this rather long 
interval: (1) the development of endometriosis by induction rather than 
implantation; (2) only minute fragments of endometrial tissue have the capacity to 
implant; (3) inhibitory effects of a "menstrual toxin" on the endometrial tissue; or 
(4) the need to induce a receptive state in the host tissue. Sanfilippo et al. [124] 
observed complete remission of endometriosis in one women with an uterus 
didelphis with unilateral imperforate vagina after creating a vaginal window. They 
speculated that under normal circumstances an immunologic mechanism may 
prevent implantation of retrogradely seeded endometrial tissue. This protective 
mechanism may be overwhelmed in cases of increased amounts of refluxed 
endometrial cells. 
A deficient uterotubal control mechanism, resulting in increased retrograde 
menstruation has also been suggested in women destined to develop 
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endometriosis. In 1924, Sampson already demonstrated a great variation in 
fallopian tube lumina, especially of the interstitial part [18]. He postulated that if all 
women had fallopian tubes with a lumen of wide diameter, the appearance of 
endometriosis would be of even greater frequency. Ayers and Friedenstab [126] 
obtained transcervical pressure profiles of the uterotubal junction at laparoscopy, 
and demonstrated a relative hypotonia at this junction in women with 
endometriosis. Bartosik eí al. [33] found that after uterine-tubal irrigation, 
endometrial tissue is refluxed more often into the peritoneal cavities of women 
with endometriosis than in those without endometriosis, which is in line with this 
theory. However, once again it remains to be proven that uterotubal hypotonia is 
a primary event in the development of endometriosis and not the result of the 
presence of endometriosis. 
An iatrogenic mechanism which may result in an increased amount of refluxed 
endometrial cells is uterine-tubal flushing for tubal patency testing or as treatment 
of endometriosis-related infertility [32-35,39,127]. These uterine-tubal flushings are 
often performed during the mid- and late follicular phase of the menstrual cycle in 
which phase optimal growth conditions exist for endometrial cells. Following 
ovulation however, the high E2 and Ρ concentrations in PF may interfere with the 
growth capacity of refluxed endometrial cells [30]. 
So far, no studies have been performed with the aim of quantifying the 
amount of refluxed endometrial cells during menstruation and after uterine-tubal 
flushing. 
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Diagnosis and classification of endometriosis 
An accurate diagnosis of endometriosis is a prerequisite for any study 
focusing on its pathogenesis and association with infertility. The diagnosis may be 
suggested by the symptoms, combined with findings at pelvic examination. But 
the diagnosis can only be confirmed at laparoscopy, starting with macroscopic 
identification of endometriotic lesions, followed by histologic examination of 
biopsied material. Several staging systems, based on laparoscopic or laparotomie 
findings, have been introduced in order to allow a valid comparison between 
homogeneous groups of women with regard to the severity of endometriosis 
[128-131]. Although these classification systems can be helpful in documenting 
the disease, none of them appears to be satisfactory [132-137]. 
Several studies have indicated that there are many macroscopically different 
forms of endometriosis, varying from the classic puckered blackish or bluished 
lesions to clear small vesicles [8,50,138-140], and peritoneal defects 
[48,49,138,141,142]. At the microscopic level, morphologically different types of 
endometriosis also exist, varying from intraperitoneal endometriotic lesions with or 
without surface epithelium and glandular openings, to retroperitoneal 
endometriosis with deeper endometriotic foci [143]. Histologic examination of 
biopsies taken at laparoscopy sometimes reveal lesions other than endometriosis, 
having macroscopically similar characteristics, for example hemangiomas and 
epithelial inclusions [8,140,144]. 
When no endometriotic lesions are seen at laparoscopy, this does not exclude 
the presence of endometriosis [6,8]. The usefulness of the laparoscope to 
diagnose or exclude endometriosis is limited in the presence of pelvic adhesions 
[6]. Furthermore, studies have shown the presence of microscopic endometriosis 
in visually normal peritoneum [145,146], although the use of peritoneal blood 
painting and near contact laparoscopy appears to increase the sensitivity of this 
method [147-149]. 
Vernon et al. [150] have indicated that there is a correlation between the 
macro- and microscopic appearance of endometriotic lesions and its biochemical 
activity. This activity was deduced from prostaglandin F production in vitro of 
biopsies from the implants. The classic powder-burn lesions were least active. 
Furthermore the prostaglandin F production in vitro of implants from women with 
a less extended disease (based on laparoscopic findings) was greater than that 
of implants from women with severe or extensive disease. 
Although the morphologic appearance and biochemical activity of 
endometriotic implants are not included as variables in any of the classification 
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systems, this may be important with regard to related complaints and infertility. 
Therefore, a major disturbing factor in all studies focusing on the pathogenesis of 
endometriosis and its association with infertility is that, so far, no accurate 
classification system exists in which the activity of the endometriotic lesions and 
their consequences for the peritoneal environment are included. Furthermore with 
regard to the control groups used in these studies, it remains uncertain whether 
these groups indeed consisted only of women without endometriosis. 
Determination of secretion products of endometriotic cells in serum and/or PF 
could be of help to devise a more precise classification system which 
incorporates the activity of the endometriotic lesions. It could also result in a 
serum and/or PF marker for endometriosis. 
After the observation that the ovarian carcinoma related antigen CA 125 was 
also elevated in women with endometriosis, studies focused on its use as serum 
marker [151-154]. The predictive value and correlation with the score of the 
Revised American Fertility Society classification system appeared to be low, 
especially with regard to minimal and mild stages of endometriosis (Table 1.3). 
Several studies measured PF CA 125 concentrations in order to evaluate whether 
this would be more predictive for endometriosis than serum concentrations [155-
158]. The concentrations of CA 125 in PF were 10-fold higher (50 - 375 arb. 
U/mL) than in serum without differences between women with and without 
endometriosis. However, dilution of PF samples to validate the assay, did not 
follow the standard dose response curve, so that the results must be considered 
invalid [156,157]. 
A more promising approach could be the determination of endometrial 
proteins in serum and/or PF, although retrograde menstruation may be a 
confounding factor. Joshi ef al. [159] determined the concentration of 
progestagen-associated endometrial protein (PEP) in serum and PF. No 
difference in mean serum PEP concentration was found between women with and 
without endometriosis, both during the proliferative and luteal phase. PEP 
concentrations generally were higher in PF than in serum. Women with severe 
endometriosis had a 10-fold higher mean PEP concentration in secretory phase 
PF than women with less extended endometriosis and controls (including both 
fertile and infertile women). They suggested that PEP concentrations in PF reflect 
the extent of ectopic endometrial growth. Unfortunately, the range of values in 
each group was not reported. 
Telimaa ef a/. [160] measured the endometrial secretory protein PP14 in 
serum, which is immunologically indistinguishable to PEP [161]. Serum 
concentrations of PP14 vary during the ovulatory cycle, the concentration 
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Table 1.3. Serum CA 125 concentrations in women with and without macroscopic 
endometriosis at laparsocopy. 
author 
no macroscopic 
endometriosis A 
NB >35U/mLc 
endometriosis 
stage l/ll 
NB >35UlmL< 
endometriosis 
stage lll/IV 
NB >35U/mLc 
Barbieri et al. [151] 55 О (0) 
Patton et al [153] 45 3 (7) 
Pittaway and Payez [154] 46 О (0) 
Fedele et al. [155] IB О (0) 
Williams et al [156] 12 0 (0) 
Moretuzzo et al. [157] 20 0 (0) 
Dawood et al. [158] 
47 3 (6) 
22 2 (9) 
92 5 (5) 
20 2 (10) 
12 1 (8) 
10 0 (0) 
44 4 (9) 
13 7 (54) 
15 3 (20) 
38 13 (34) 
19 7 (37) 
10 0 (0) 
23 8 (35) 
* normal peh/is 
B
 number of women 
0
 values are number of samples with percents in parentheses 
increasing in the late luteal phase, being highest at the time of the menstrual 
bleeding t162]. In contrast to Joshi et al. [159], they found significantly elevated 
serum PP14 concentrations in samples obtained between cycle day 5 and 20 of 
women with severe endometriosis [160]. The mean serum PP14 concentration in 
women with mild endometriosis was slightly but not significantly higher than in 
healthy control women. Since a rather large overlap in values was observed 
between both groups of women, it would be interesting to determine whether the 
endometriotic foci are more active in women with mild endometriosis and high 
serum PP14 concentrations. 
The presence of anti-endometrial (and endometriotic) auto-antibodies in serum 
has been evaluated as serum and/or PF marker for the presence of 
endometriosis [86-88]. Table 1.4 shows the true positive and false positive 
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Table 1.4. Presence of anti-endometrial auto-antibodies in serum of women with and without 
macroscopic endometriosis at laparoscopy 
author 
Wild and Shivers [86] 
Chihal et al [87] 
Meek et al [88] 
Meek et al [88] 
assay* 
IF 
PH 
IF 
ID 
infertile 
with 
endometriosis 
NB 
34 
23 
20 
20 
positive c 
24(71) 
17 (74) 
14 (70) 
15 (75) 
infertile 
no 
endometriosis 
N B positive c 
8 4 (SO) 
fertile 
Na 
38 
17 
20 
20 
positive c 
2(5) 
0(0) 
12(60) 
2(10) 
* IF = immunofluorescence 
PH = passive hemagglutination (positive = bter greater than 1 -32) 
ID = immunodiffusion 
B
 N = number of women 
c
 values are number of women with percents in parentheses 
percentages in women with and without macroscopic endometriosis for the 
different assay methods. None of the studies found a correlation between the 
presence of anti-endometrial auto-antibodies and the severity of endometriosis as 
determined at laparoscopy [86-89]. It was suggested that the presence of anti-
endometrial auto-antibodies may correlate more with the degree of infertility than 
the clinically apparent severity of the disease [86]. Chihal ei al. [87] used a 
passive hemagglutination assay by which serum titers can be measured. They 
observed significantly lower titers in women with a good clinical response to 
danazol therapy and stated that sequential determination of anti-endometrial auto-
antibody titers could be helpfull in assessing the efficacy of pharmacologic 
therapy for endometriosis. 
As a conclusion, endometriosis appears to be a heterogeneous group of 
lesions both macro- and microscopically. It is obvious that the current 
classification systems which only include number, size, and location of the 
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endometriotic lesions are of limited value. This can also explain the different study 
results regarding correlations between the severity of the disease and symptoms 
or infertility. 
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Endometriosis and infertility 
Endometriosis has been traditionally associated with infertility, mainly based on 
the fact that the prevalence of endometriosis is high among women with fertility 
problems [5,6,8]. In the more severe types of endometriosis, this association is 
conceivable because adhesions and endometriomas give rise to anatomic 
distortions leading to a disturbed ovum pick-up mechanism. However, in women 
with endometriosis and no anatomic distortion, the fertility rates also appear to be 
reduced [163-167], although this has been questioned by some authors 
[168,169]. The way by which endometriosis is associated with infertility in the 
absence of an anatomic distortion remains to be established [170]. Nearly all 
hypotheses explaining the association between endometriosis and infertility 
attribute an important role to the peritoneal environment (Figure 1.2). 
retrograde 
menstruation 
/ 
endometriosis 
alterations in 
peritoneal 
environment 
/ 
I I 
infertility 
Figure 1.2. Association between retrograde menstruation, endometriosis, and infertility in which 
the peritoneal environment has an important role. Closed arrows indicates 
interactions as suggested in literature. The interaction as indicated with the open 
arrow is suggested in this thesis (page 22: endometriosis inducing an uterotubal 
hypotonia). 
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The LUF syndrome as cause of infertility and endometriosis has already been 
discussed in the section on the pathogenesis of endometriosis (page 15). In 
short, the concentrations of both E2 and Ρ are only sligthly elevated during the 
early luteal phase in women with LUF. This hormonal environment may favour 
implantation of refluxed endometrial cells during menstruation. Once established, 
endometriosis can aggravate infertility [171]. The reason why some women 
develop LUF may be related to the sensitivity to be stressed [171,172] which may 
also account for the higher serum-prolactin levels reported in some women with 
endometriosis [173-174]. Prolactin secretion indeed is stress related. However, 
since repeated LUF cycles are rare [71,76,77], LUF itself appears to be of less 
importance in endometriosis-related infertility. 
Drake ef a/. [175] found significantly higher PF volumes in infertile women with 
endometriosis and suggested that PF as such may be involved in the genesis of 
endometriosis-related infertility. Whereas various reports confirmed the observation 
of Drake eí al. [175] regarding higher PF volumes in women with endometriosis 
[88,101,104,106,107,110,176], others did not find significant differences 
[30,64,103,109,117,177-179]. Several reports do not mention the phase of the 
menstrual cycle during which the PF was collected. Studies have indicated that 
the PF volume in women with endometriosis is significantly higher compared to 
controls especially in the luteal phase of the menstrual cycle [104,107,110]. 
Furthermore, various reports again are inaccurate due to inadequate selection 
and definition of the control group. When evaluating endometriosis-related factors 
leading to infertility, the control group should ideally consist of infertile women 
without endometriosis. In addition, both groups (infertile women with and without 
endometriosis) should be standardized for other infertility-related factors. In only 
one (retrospective) study the data for both cycle period and diagnostic group 
were standardized [106]. In this study women with macroscopic endometriosis 
had a significantly increased mean PF volume compared to normal fertile women 
and infertile women with either adhesive disease or unexplained infertility. 
As already discussed in the section on the pathogenesis of endometriosis 
(page 18), elevated numbers of more activated PM have frequently been found in 
PF of infertile women with endometriosis [31,101-108]. As a result, monokines 
produced by these activated PM are found to be elevated in PF of women with 
endometriosis [111-114]. These alterations in PF volume and constituents can be 
characterized as an intraperitoneal exudate. The stimulus eliciting this 
intraperitoneal inflammation may be endometriosis. However, recent studies 
suggest that it is a response to retrograde menstruation [117,118]. The fact that 
surgical or medical treatment of women with minimal and mild stages of 
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endometriosis does not improve pregnancy and/or monthly fecundity rates 
[132,167,168,170,180,181], also suggests that endometriosis and infertility are not 
directly related to one another. 
Several mechanisms have been suggested and/or evaluated by which these 
alterations in PF constituents may cause infertility: 
- diminished sperm motility 
Oak ef al. [176] found a significant reduction in the percentage of motile sperm 
when added to PF of women with endometriosis compared with fertile women. It 
has been suggested that this decreased motility of spermatozoa is mediated by 
elevated levels of lymphokines (gamma-interferon) and monokines (TNF) in PF 
[182]. In contrast, Stone and Himsl [183] did not find a significant difference in 
the percentage of motile sperm between women with and without endometriosis. 
They investigated the effect of PF on sperm motility in a group of women 
undergoing diagnostic laparoscopy for infertility after artificial insemination. 
However, their control group consisted of women with unexplained infertility. Oak 
et al. [176] demonstrated that in women with unexplained infertility, sperm motility 
is reduced as much as in women with endometriosis. 
- increased sperm phagocytosis 
An increased phagocytosis of spermatozoa by endometriosis-related PM has 
been reported [184], although this could not be confirmed by others [109]. 
- ovulatory disorders 
Auto-immune changes in women with endometriosis have been related to 
ovulatory disorders. In addition to observed elevations in anti-endometrial auto-
antibody titers in serum, and cervical and vaginal secretions of these women, 
elevated antibody titers to ovarian cells (both theca and granulosa cells) have 
also been reported in some of these women [85]. This may be relevant for 
reported ovulatory disorders in women with endometriosis, i.e. luteal phase 
deficiency [185], a delayed rise in progesterone level after the LH-surge [53], 
reduction in fertilisation rate of ova in vitro [186], and smaller follicles with lower 
pre-ovulatory serum E2 levels [80]. 
- impaired sperm-ovum interaction 
Halme ef al. [187] investigated sperm-ovum interaction by adding the 
complement-inactivated and cell-free fraction of PF to the medium of the zona-
free hamster egg sperm penetration assay. The test results were not affected by 
either PF obtained from fertile and infertile women with and without endometriosis. 
Chacho ef al. [104,188] used culture media of PM for the zona-free hamster egg 
sperm penetration assay. In general, the use of these culture media had adverse 
effects on the test results. PM from women without endometriosis were equally 
effective at decreasing the percentage of penetration as PM from women with 
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endometriosis. A difference in sperm-ovum interaction beween women with and 
without endometriosis could therefore only be explained by an increased number 
of PM. Again, it has been suggested that these adverse effects of the 
supernatants of PM cultures may be attributable to an increased secretion of 
lymphognes (gamma-interferon) and monokines (TNF) [189]. 
- interference with ovum-tuba fallopii interaction 
Suginami ef a/. [190] incubated hamster-oviducts with the mouse-ovum/cumulus 
complex in human PF and investigated the cumulus-fimbriae interaction. They 
concluded that ovum capture by the oviductal fimbriae was inhibited in the 
presence of PF from women with endometriosis. This inhibition appeared to be 
caused by a membrane developing on the fimbriae when exposed to 
endometriosis-related PF [191]. 
- impaired embryo development 
Morcos ef al. [192] focused on early embryo development and added 
complement-inactivated PF to the culture medium of two-cell mouse-embryos. 
They found an adverse effect of complement-inactivated PF samples from women 
with endometriosis upon the development of these mouse-embryos. In serum of 
women with endometriosis an inhibiting factor on early embryogenesis has also 
been reported [193]. It has been suggested that this negative influence on early 
embryo development may be mediated by an elevated IL-1 activity [111]. The 
addition of recombinant IL-1 to the culture medium of two-cell mouse-embryos in 
concentrations similar to those present in PF of women with endometriosis, has 
adverse effects upon the development of these embryos. Awadalla et al. [109] 
however, did not observe adverse effects of PF and PM supernatants from 
infertile women with endometriosis on mouse-embryo development in vitro. 
- interference with early embryo implantation 
Auto-immune changes resulting in antibody / complement deposits in 
endometrium have been proposed to interfere with early embryo implantation 
[90], although this could not be confirmed by others [91]. 
Increased PF prostaglandin concentrations have been found in PF of women 
with endometriosis [31,179,194-196], although conflicting data have been reported 
[104,108,177,178]. Increased concentrations of PF prostaglandins have also been 
found in women with unexplained infertility and with tubal disorders when 
compared to fertile women [179]. Some studies relate these higher prostaglandin 
concentrations in endometriosis-related PF to activated PM [31,195], others 
propose these prostaglandins to be produced by the endometriotic spots 
themselves [194,198], or by the pelvic peritoneum [197]. Increased PF 
prostaglandin concentrations may have adverse effects on the mechanism of 
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ovulation, the function of the corpus luteum, or may cause an altered tubal 
transport of the zygote, resulting in infertility [198,199]. 
Syrop and Halme [200] investigated the correlation between several sets of 
data regarding the peritoneal environment (PF volume, PM number and 
concentration) and the fertility rate during a period of 2 years. In women with 
macroscopic endometriosis, an inverse relationship was found with the PF 
volume. No correlation existed with the number and concentration of PM. This 
may indicate that these alterations are not responsible for infertility related to, and 
possibly induced by endometriosis. However, these data do not exclude the 
possibility that qualitative differences in PM activity are responsible for 
endometriosis-related infertility. 
In conclusion, many theories have been proposed to explain the association 
between endometriosis and infertility. Endometriosis has been explained as a 
result of infertility, others have explained infertility as a result of endometriosis, 
and yet others have introduced retrograde menstruation as a mediating factor for 
both endometriosis and infertility. However, none of these theories is completely 
satisfactory. 
(for a more detailed review see: Muse and Wilson [173], Syrop and Halme [201], 
and Dunselman [202]) 
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Outline of this thesis 
During the last decade, retrograde menstruation has regained interest as an 
important factor in the development of endometriosis and infertility. An increased 
amount of retrograde menstruation may explain both the development of 
endometriosis and related infertility. Although the endometrial implantation theory 
has become widely accepted as the main mechanism for the development of 
endometriosis, coelomic metaplasia can not be excluded. No study has been 
carried out which focusses on the presence and amount of adhering and 
proliferating endometrial cells in PF. 
The main objective of this thesis was to investigate the amount of endometrial 
epithelial cells with adhering and proliferating properties in PF, as a consequence 
of retrograde menstruation and of uterine-tubal flushing. For this purpose we 
cultured the cell pellet of PF. Since PF also contains mesothelial cells, it was 
important to develop a reliable method to identify endometrial epithelial cells 
among proliferating mesothelial cells. Monoclonal antibodies (MAb) can be used 
to distinguish and characterize different epithelial tissues [203,204]. We therefore 
compared the ¡mmunocytochemical marker profile of endometriotic epithelial, 
endometrial epithelial, and mesothelial cells. In chapter 2 the results of this study 
will be discussed. In addition, a new MAb (NEND-3), developed against 
endometrial epithelial cells, will be described. 
In chapter 3, we will introduce the culture-method to identify and estimate the 
amount of endometrial epithelial cells in PF capable of adherence and 
proliferation in vitro. PF was obtained both from women with and without 
macroscopic endometriosis during the early follicular phase (cycle day 1 to 7). 
We also focused on the association between endometriosis and LUF. It has 
been suggested that high concentrations of E2 and Ρ in PF after ovulation 
adversely affect the growth potential of refluxed endometrial cells. Several studies 
differ in their assessment of the value of these changes in Ej and Ρ levels in PF 
around the time of ovulation for the retrospective diagnosis of ovulation or the 
occurrence of LUF. Chapter 4 describes a study in which changes in E2 and Ρ 
concentrations in PF were determined around the time of ovulation with the use 
of ultrasound for ovulation detection. 
Uterine-tubal flushings are performed for tubal patency testing and as 
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treatment of endometriosis-related infertility. This may result in an iatrogenic 
contribution to the development of endometriosis. The amount of refluxed 
endometrial epithelial cells with adhering and proliferating properties was 
estimated after uterine-tubal irrigation during various stages of the menstrual cycle 
in infertile women. Furthermore the influence of high Ej and Ρ concentrations in 
culture medium comparable to postovulatory levels in PF, and of methylene blue 
on the growth potential of these endometrial epithelial cells was examined. TTie 
results will be described in chapter 5. 
Both endometriotic and endometrial cells contain CA 125. The amount of 
retrograde menstruation as well as the presence of endometriosis therefore may 
influence the PF CA 125 concentration. However, so far the method (one-step 
IRMA) used to measure the CA 125 concentration in PF must be considered 
invalid because serially diluted PF samples did not follow the standard dose-
response curve. In chapter 6 we introduce the two-step IRMA for a reliable 
measurement of PF CA 125 concentrations. 
Peritoneal fluid CA 125 concentrations and total amounts during various 
phases of the menstrual cycle in women with several infertility-related factors, as 
determined using the assessed two-step IRMA, will be presented and discussed 
in chapter 7. 
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Chapter 2 
Immunocytochemical markerprofile of endometriotic 
epithelial, endometrial epithelial, and mesothelial cells: a 
comparative study 
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I.J.Y. de Ronde, T.G.J.M. Hanselaar, R. Rolland 
(European Journal of Obstetrics, Gynecology and Reproductive Biology: in press) 
Abstract 
A comparative immunocytochemical study was performed on endometriotic 
epithelial versus endometrial epithelial and normal mesothelial cells in order to 
obtain further evidence for either the endometrial implantation or mesothelial 
metaplasia theory. The three cell types could not be distinguished by keratin 
subtyping, using monoclonal antibodies (MAb) to keratins 5,7,8,14,18, and 19. 
The epithelial markers HMFG-2 and BW 495/36, and a newly developed MAb 
NEND-3 (against endometrial cells) discriminated between generally negatively 
reacting mesothelial cells and positively reacting endometrial and endometriotic 
epithelial cells. The MAb NEND-3 appeared to be specific for endometrial (and 
endometriotic) epithelial cells since no reactivity with other epithelial cell types was 
found. Typing with MAbs against ovarian carcinoma related antigens (OV-TL 3, 
OV-TL 10 and OC 125) did not permit sufficient distinction. The marker profile of 
cultured endometrial, endometriotic and mesothelial cells confirmed the 
immunocytochemical findings on frozen sections. Although the data are consistent 
with the endometrial implantation theory, mesothelial metaplasia can not be 
excluded with regard to the histogenesis of endometriosis since metaplastic 
mesothelium may express different antigen markers. 
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Introduction 
Endometriosis is a common gynecologic disease, with its main symptoms 
being dysmenorrhoea, dyspareunia, pelvic pain and infertility. The prevalence is 
estimated in different patient populations between less than 1% to as high as 
50%, the highest prevalence being reported in women with fertility problems [1]. 
The histogenesis of endometriosis is classically explained by the endometrial 
implantation theory of Sampson [2]. This theory assumes that endometriosis 
arises through implantation of endometrial cells on the pelvic peritoneum, mainly 
as a result of retrograde menstruation. The involvement of retrograde 
menstruation as a significant factor in the pathogenesis of endometriosis is 
supported by the anatomic distribution of endometriosis [3], as well as by the 
fact that endometriosis is correlated with short cycle Ienghts [4], and uterine 
outflow obstructions [5]. However, the possibility of a factor existing in the 
menstrual debris which induces metaplasia of cells of the mesothelial lining 
resulting in endometriosis can not be excluded [6]. Factors of stromal origin 
could be of particular interest since experiments with mice have indicated that 
regional differentiation of Müllerian epithelium during morphogenesis is due to 
inductive activities of the underlying stromal cells [7]. Embryologically the 
endometrial epithelium (Müllerian derivate) is a product of the coelomic wall. 
Monoclonal antibodies (MAbs) can be used to distinguish and characterize 
different epithelial tissues [8,9]. The current study was undertaken to compare the 
immunocytochemical marker profile of endometriotic epithelial cells versus 
endometrial epithelial and mesothelial cells, in order to obtain further evidence for 
either the endometrial implantation or mesothelial metaplasia theory. A panel of 
MAbs to different keratins was used in combination with epithelial markers BW 
495/36 and HMFG-2, and with MAbs to ovarian carcinoma related antigens also 
known to be expressed on endometrial cells. In addition, a new MAb (NEND-3) 
was developed to identify normal endometrial epithelial cells. 
Material and Methods 
Tissues and cells 
Fresh normal human tissues were obtained immediately after surgery, and 
either frozen in liquid nitrogen and stored at -80oC, or processed for cell culture. 
Parallel tissue samples were processed routinely for hematoxylin and eosin (H&E) 
stained paraffin sections for histodiagnosis. Endometriotic tissues were obtained 
from patients suffering ovarian endometriosis and undergoing ovariectomy (n=5). 
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Ovarian tissues were also obtained from patients submitted for ovariectomy 
because of benign cysts (n=15). In seven of these ovarian tissue fragments no 
mesothelial lining could be identified, probably because of intense digital 
manipulation during extirpation. Furthermore, in 10 patients biopsies (2-3 mm) 
were obtained at laparoscopy from pelvic peritoneal sites with and without 
macroscopical aspect of endometriosis. Endometrium, in the proliferative phase 
(n=10) or in the secretory phase (n=10), was obtained from patients submitted 
for uterus extirpation for reasons not related to endometrial pathology. Cell 
suspensions from peritoneal fluid (PF) before and after uterine-tubal irrigation 
were obtained from patients at laparoscopy during the late proliferative phase 
because of infertility (n=10). 
Culture method 
Pelvic peritoneal biopsies, from each patient (n=10) one with and one without 
macroscopical aspect of endometriosis, and PF cell suspensions before and after 
uterine-tubal irrigation (n=10) were cultured according to the method as 
described by Mungyer et al. [10]. The duration of culture was 7 days in which 
the medium was changed twice. 
lmmuno(histo)chemical assays 
The indirect immunofluorescence and immunoperoxidase technique on frozen 
sections as well as on cell cultures were performed essentially as described 
previously [9,11]. Frozen sections (4-5//m thick) were cut on a cryostat, air dried, 
and briefly fixed (2 min.) in cold methanol (-20oC). The following mouse MAbs 
were used: 
(A) Anti-keratins: 
OV-TL 12/5 directed against keratins 5, 7, 14 and 19, being used as a broad 
spectrum anti-keratin [9]; 
RCK 102 to keratins 5 and 8 [12]; 
OV-TL 12/30 [9] and RCK 105 [13] reacting specifically with keratin 7; 
RCK 106 [14], RGE 53 [13], and CK 18-2 [12], specifically recognizing 
epitopes on keratin 18; 
(B) Epithelial markers: 
BW 495/36 directed against a 200 kilo-Dalton glycoprotein of epithelial cells 
[9.15]; 
HMFG-2 raised against delipidated preparation of the human fat milk globule 
and characterized as epithelium-specific [16]; 
(C) Ovarian carcinoma-associated antigens: 
OV-TL 3 [11], OV-TL 10 [9], and OC 125 [17]; 
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(D) NEND-3 was obtained from a fusion of Sp2/0-Ag14 myeloma cells with 
spleen cells from mice immunized with three injections of 6x106 human 
endometrial epithelial cells in complete Freund's adjuvants. The endometrial 
cell layer was peeled off from the myometrium of an extirpated uterus and 
cut into small pieces. An endometrial cell suspension was prepared by 
treatment with trypsin (0.25% in culture medium RPMI-1640), followed by 
washing in culture medium RPMI-1640 supplemented with 10% fetal bovine 
serum and incubated for 2 hours in a 5% C02 incubator. While stromal cells 
adhered to the plastic of culture flasks, epithelial cells did not within 2 hours. 
Epithelial cells were cryopreserved in medium containing 10% fetal bovine 
serum and 10% dimethylsulfoxide (DMSO, Merck, Darmstadt, FRG) and 
stored in liquid nitrogen. Eight week-old male Balb/c mice were immunized 
by four subsequent intraperitoneal injections, at 2-3 week intervals, with 6x10e 
endometrial epithelial cells. Three days after the last injection the spleen was 
aseptically removed, and fusion was performed as described previously [11], 
based on the technique as described by Kohier and Milstein [18], and 
modified by Kennet et al. [19]. The hybridoma supernatants were screened 
initially for a positive immunofluorescence reaction on cryostat sections of 
normal endometrium concomittant with a negative reaction against digestive 
tract epithelium. The reactivity pattern of NEND-3 with tissues other than 
endometrium, endometriosis and normal mesothelium was also tested 
including the epithelial lining of two ovarian inclusion cysts, known to be of 
mesothelial origin. 
Results 
Immunohistochemlcal reactivity of tissue sections (Table 2.1) 
All MAbs against different keratins stained with endometrial and endometriotic 
epithelial cells (figure 2.1-a) as well as the mesothelial cells lining the ovaries 
(figure 2.1-е). In contrast to endometrial and endometriotic epithelial cells (figure 
2.1-b), mesothelial cells covering the ovary did not react with the epithelial marker 
BW 495/36. In one case, however, a focally positive reaction with MAb BW 495/36 
was found, being a cluster of tall cells between the flattened, non-reacting surface 
cells of a normal ovary (figure 2.1-f) without macroscopical evidence of 
endometriosis. In addition to a homogeneously positive staining of endometrial 
and endometriotic epithelial cells with MAb HMFG-2 (figure 2.1-c), 2 out of 8 
ovarian mesothelial samples also reacted positively. The ovarian carcinoma 
markers OV-TL 3 and OV-TL 10 gave a negative to weakly positive reaction with 
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Table 2.1. Immunocytochemical reactivity of various monoclonal antibodies with endometrial, 
endometriotic and ovarian germinal epithelial cells.A 
MAb 
OV-TL 1215 
RCK 102 
RCK 105 
OV-TL 12/30 
CK18-2 
RCK 106 
RGE 53 
BW 495/36 
HMFG2 
OV-TL 3 
OV-TL 10 
OC 125 
NEND-3 
antigen 
recognized 
keratins 5/7/14/19 
keratins 5/8 
cytokeratin 7 
cytokeratin 18 
epithelial marker 
epithelial marker 
ovarian carcinoma 
related antigen 
ovarian carcinoma 
related antigen 
ovarian carcinoma 
related antigen 
endometrial 
proliferative 
+ + 
+ + 
+ + 
+ + 
+ 
+ 
+-
-
_ 
+ 
+-
+ 
10/10 
10/10 
10/10 
10/10 
10/10 
10/10 
3/10 
7/10 
10/10 
9/70 
1/10 
10/10 
epithelial cells 
secretory 
+ + 
+ + 
+ + 
+ + 
+ 
+ 
+-
-
+-
-
+ 
+-
+ 
+-
10/10 
10/10 
10/10 
10/10 
10/10 
10/10 
5/70 
5/70 
6/70 
4/10 
9/10 
1/10 
4/70 
6/10 
endometriotic 
epithelial 
cells B 
+ + 
+ + 
+ + 
+ + 
+ 
+ 
+-
-
+-
-
+ 
+-
+ 
+-
10/10 
10/10 
10/10 
10/10 
10110 
10/10 
4/10 
6/10 
5/10 
5/10 
8/70 
1/10 
1/10 
6/10 
4/10 
ovarian 
me. cnthfìh'nl 
a\JU IVIIOJ 
cells 
+ + 8/8 
+ + 8/8 
+ + 8/8 
+ + 8/8 
-
+ 
+-
-
+-
-
+ 
+-
-
8/8 c 
2/8 
6/8 c 
4/8 
4/8 
2/8 
6/8 
7/8 
2/8 
5/8 c 
8/8 c 
+ + = strong positive staining; + = positive staining; +- = weak, traces of staining 
B
 ovarian endometriosis (n=5) and peritoneal endometriosis (n=5) 
0
 of one ovary a small fragment of the epithelial lining positive 
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endometrial and endometriotic epithelial cells, while traces of reactivity could also 
be found on some mesothelial cells. The MAb OC 125 reacted with the epithelial 
cells of all endometrial and the majority of endometriotic tissues (9 out of 10). 
Weak to moderate binding of MAb OC 125 was observed on the lining 
mesothelium of 3 out of 8 ovaries. The newly developed MAb NEND-3 reacted 
positively with endometrial and endometriotic epithelial cells (figure 2.1-d,g). No 
staining was observed in the mesothelial cells covering the ovary. The MAb 
NEND-3 therefore discriminated well between normal mesothelial cells versus 
endometrial and endometriotic epithelial cells. The epithelial lining of two germinal 
inclusion cysts did also not react with MAb NEND-3 (Table 2.2). The same small 
fragment of tall ovarian mesothelial cells (described above) however, which 
stained with MAb BW 495/36, also stained with MAb NEND-3. With regard to 
endometrium, the apically localized staining with MAb NEND-3 on secretory 
glandular epithelia was generally weaker than that on proliferative glandular 
epithelia. In addition, the MAb NEND-3 did not react with a large variety of other 
epithelial cell types as summarized in Table 2.2, indicating that MAb NEND-3 may 
be considered as an anti-endometrial (and anti-endometriotic) epithelium antibody. 
Morphology and immunocytochemical reactivity of endometrial and 
endometriotic epithelial, and mesothelial cell cultures 
It has been shown previously that in cultures of cell suspensions obtained 
from PF before and after uterine-tubal irrigation, endometrial epithelial and 
mesothelial cells can be distinguished morphologically [10,20]. Endometrial 
epithelial cells upon culture, establish characteristic tadpole-shaped cells, forming 
larger colonies of cells curling around each other in a whorling pattern. 
Mesothelial cells in culture, however, represent a population of irregular elongated 
cells becoming flattened and polygonal with age. 
In the current study, tadpole-shaped (endometrial epithelial) cells could be 
identified in 8 out of 10 cultures of cell suspensions from PF after uterine-tubal 
flush, whereas the cultures of cell suspensions from PF before uterine-tubal 
irrigation consisted of mesothelial cells only. Applying the MAbs described above, 
both endometrial epithelial and mesothelial cells showed the same marker profile 
as in frozen tissue sections (figure 2.1-h,i). This indicated that in cell cultures 
endometrial epithelial cells could also be distinguished from mesothelial cells with 
the MAbs BW 495/36, HMFG-2 and NEND-3. Characteristic tadpole-shaped cells 
were noted in 7 out of 10 cultures of biopsies of macroscopically pelvic peritoneal 
endometriosis (figure 2.1-j). This correlated well with the results of parallel tissue 
biopsies for H&E stained paraffin sections (Table 2.3). In 9 out of 10 cases in 
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Table 2.2. Immunohistochemical reactivity of NEND-3 monoclonal antibody 
organ (at least 2 tested) tissue reactivity 
skin 
tonsill 
stomach 
small intestinal epithelium 
colonic epithelium 
liver 
kidney 
lung 
oviductal epithelium 
uterus 
vagina 
ovary 
cormfied epithelium 
sweat glands 
sebaceous glands 
hair follicle 
squamous epithelium 
lymfoid cells 
surface epithelium 
glandular cells 
parenchymal cells 
kupffer cells 
bile ductules 
glomerulus 
proximal tubules 
distal tubules 
trachea epithelium 
bronchial epithelium 
alveolar epithelium 
endometrial epithelium 
endocervical epitheium 
ectocervical epithelium 
squamous cells 
mesothelium 
oocytes 
inclusion cyst epithelium (n=2) 
which the diagnosis endometriosis was made at laparoscopy on macroscopical 
aspects, this diagnosis was confirmed (n=6) or denied (n=3) with both 
techniques (culture and H&E). In one patient (nr. 7) the biopsy was too small for 
a reliable histodiagnosis. Furthermore, both techniques (culture and H&E) 
diagnosed endometriosis in one patient (nr. 9) in which the pelvic peritoneal 
biopsies were not suspected macroscopically of endometriosis. Again, the 
tadpole-shaped cells stained with MAbs BW 495/36 (figure 2.1-k), HMFG-2 and 
NEND-3, therefore showing the same marker profile as endometrial and 
endometriotic epithelial cells in frozen tissue sections. 
Discussion 
The ovary is the most common site of endometriosis [3]. Implantation of 
endometrial cells on particular the ovary could be favoured by the close proximity 
of the ovaries to the tubal ostia, the irregular contour affording better attachment 
of implants, appropriate hormonal environment as well as cyclic disrupture of the 
epithelial lining at ovulation [3]. However, these arguments do not exclude 
development of endometriosis by metaplastic transformation of this germinal 
epithelium. Kerner et al. [21 ] showed the presence of unusual ovarian mesothelial 
inclusions in 10% of ovarian endometriosis. They suggested a common stimulus 
responsible for the development of both conditions from the multipotential pelvic 
Figure 2.1: 
Immunofluorescence and immunoperoxidase micrographs of frozen sections and cultures of 
endometriotic, endometrial and mesothelial tissues/cells with various MAbs: 
a-d) ovarian endometriosis with CK 18-2 (a), BW 495/36 (b), HMFG-2 (c), and NEND-3 (d) (200x). 
e-f) ovarian germinal epithelium with CK 18/2 (e) and BW 495/36 (f) Note the cluster of positively 
reacting tall cells between the flattened, non-reacting cells (300x). 
g) proliferative endometrium with NEND-3 Note the apically localized staining pattern of the 
epithelial cells (250x). 
h-i) uterme-tubal flush añer 7 days of culture, initially incubated with BW 495/36 (h), afterwards 
with OV-TL 12/5 (ι). BW 495/36 stains only the endometrial epithelial cell colony whereas OV-
TL 12/5 also stains the surrounding mesothelial cells as proof of their epithelial nature (300x). 
¡-к) peritoneal endometriosis after 7 days of culture, before (phase contrast, j) and after 
incubation with BW 495/36 (k) Note the presence of tadpole-shaped endometriotic epithelial 
cells, staining with BW 495/36 (i=250x, k=30Qx). 
Scale bar indicates 50 ¡un. 
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Table 2.3. Diagnosing endometriosis by identification of tadpole'-shaped cells in culture 
versus H&E stained paraffin sections 
patient 
number 
biopsy endometriosis * 
culturel H&E 
biopsy peritoneum 
culture ' H&E 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
+ 
+ 
* clinical suspected of endometriosis 
3
 + = identification of 'tadpole'-shaped cells in culture 
c
 H&E diagnosis connective tissue (n=2) and haemorrhage (n=1) 
D
 no H&E diagnosis, biopsy too small for reliable diagnosis 
mesothelium. In the present study, using a panel of MAbs, the marker profile of 
endometriotic epithelial cells (of both ovarian and peritoneal localisations) was 
compared to that of endometrial epithelial and ovarian mesothelial cells. MAbs to 
different keratins (5-7-8-14-18-19) did not reveal any distinction between the three 
cell types, which is consistent with previous reports [12,13]. In contrast, both 
epithelial markers used in this study (HMFG-2 and BW 495/36) discriminated 
between endometrial and endometriotic epithelial cells versus mesothelial cells. 
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This distinction was most pronounced with the MAb BW 495/36 which reacted 
with all endometrial and endometriotic epithelial cells and none of the mesothelial 
cells covering the ovary. The newly developed MAb NEND-3 also discriminated 
between nonreacting surface epithelium of the ovary and positively reacting 
endometrial and endometriotic epithelial cells. Furthermore, in contrast to the 
epithelial marker BW 495/36, NEND-3 appeared to be specific for only 
endometrial (and endometriotic) epithelial cells. The reactivity of NEND-3 with 
endometrial and endometriotic epithelial cells was located apically. The 
observation that the reactivity was stronger on proliferative than on secretory 
endometrium may indicate that the antigenic determinant recognized by NEND-3 
is hormone dependent. This is supported by the recent observation that atrophic 
endometrium hardly shows any reaction with NEND-3 (data not shown). Typing 
with the ovarian carcinoma related MAbs OV-TL 3 and OV-TL 10 did not permit 
sufficient distinction between endometrial epithelial and mesothelial cells, since 
both populations of cells showed variable weak staining with these antibodies. 
The MAb OC 125 reacted with the majority of endometrial and endometriotic 
epithelial cells but also with a minority (3 out of 8) of the ovarian mesothelial cells. 
The observed differences in antigenicity between endometrial and endometriotic 
epithelial cells versus normal mesothelial cells, as recognized by the MAbs BW 
495/36, HMFG-2, and NEND-3, are consistent with the endometrial implantation 
theory. However, it does not exclude the possibility of mesothelial metaplasia. The 
epithelial lining of ovarian inclusion cysts, known to be of mesothelial origin, 
express the epitope for BW 495/36 [22]. Ovarian carcinoma, of which 90% is 
believed to originate from the mesothelial lining, also stains positively with the 
MAbs BW 495/36 and HMFG-2 [9,23]. Indeed, if mesothelium undergoes 
metaplastic transformation to endometrial-like tissue, expression of endometrial-
like antigens (including the epitope for NEND-3) is likely to occur. 
Several studies have focused on the use of MAb OC 125 to detect the 
antigenic determinant CA 125 in serum and PF, as marker for the presence of 
endometriosis. The results with regard to sensitivity were disappointing [24,25]. 
The fact that, in contrast to MAb OC 125, MAb NEND-3 appears to be specific 
for endometrial and endometriotic epithelial cells, may be interesting for its use as 
marker for endometriosis, when indeed the epitope for MAb NEND-3 also can be 
detected in PF or serum. A study focusing on this issue is in progress. 
In cultures of cell suspensions of PF obtained before and after uterine-tubal 
flush, mesothelial and endometrial epithelial cells could be distinguished 
morphologically. The identification of endometrial epithelial cells in PF after 
uterine-tubal flushing is in agreement with previous reports [10,20]. Also in 
cultures prepared from biopsies of peritoneal endometriosis, characteristic 
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tadpole-shaped cells were identified. The reaction of these cultured endometrial 
epithelial, endometriotic epithelial and mesothelial cells with the MAbs BW 495/36, 
HMFG-2 and NEND-3 did not differ from frozen sections, the results regarding 
mesothelial cells with BW 495/36 and HMFG-2 being consistent with previous 
observations on cultured ascitic mesothelial cells [9]. The use of these MAbs 
simplified the identification of endometrial and endometriotic epithelial cells in 
culture, especially when developing among proliferating mesothelial and stromal 
cells. The presence or absence of tadpole-shaped cells in cultures from pelvic 
peritoneal biopsies appeared to correlate well with the presence or absence of 
endometriosis in H&E stained paraffin sections of parallel biopsies. In three 
patients in which the biopsies were taken from peritoneum macroscopically 
suspected of endometriosis, with both techniques (culture and H&E) this 
diagnosis could not be confirmed. In contrast, in one patient endometriosis was 
diagnosed both histologically and by the culture technique, whereas the biopsies 
were taken from peritoneum macroscopically considered as being normal. This 
again focus on the possibility of microscopic endometriosis [26], which also can 
explain the small fragment of ovarian epithelium that reacted positively with MAbs 
BW 495/36, HMFG-2, and NEND-3. Furthermore it once more underscores the 
lack of reliability in laparoscopic assessment and staging of endometriosis which 
method is used in the majority of studies evaluating the influences of 
endometriosis on fertility and effectiveness of treatment [27]. However, since 
histologic examination only concerns the biopsy and not the entire peritoneal 
lining, it will not improve our ability of identifying and staging endometriosis by 
visual assessment at laparoscopy. 
In conclusion, the marker profiles of endometriotic and endometrial epithelial 
cells were identical, and could be distinguised from normal mesothelial cells both 
in vivo and in vitro. Although these results are consistent with the endometrial 
implantation theory, they do not exclude the mesothelial metaplasia theory with 
regard to the histogenesis of endometriosis. 
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Chapter 3 
Endometrial epithelial cells in peritoneal fluid during the early 
follicular phase. 
R.F.P.M. Kruitwagen, LG. Poete, W.N.P. Willemsen, I.J.Y. de Ronde, P.H.K. Jap, 
R. Rolland 
(Fertility and Sterility 55:297-303, 1991) 
Abstract 
Peritoneal fluid (PF) was obtained during the early follicular phase in 24 
women at laparoscopy as part of infertility investigation. The cells present in PF 
were pelleted and cultured. Developing endometrial epithelial cell colonies were 
identified in 19 women (79%). Identification of these cell colonies was facilitated 
using the monoclonal antibody BW 495/36 as specific marker. The number of 
endometrial epithelial cell colonies showed a large variation (1 to 200 or more / 
PF sample). No significant distinction in incidence and number of cell colonies 
was found between women with minimal (n=11) and without endometriosis 
(n=12). A significant correlation with number of cell colonies was found in women 
with infertility and no mechanical and male infertility factors. These data indicate 
that retrograde transport of viable endometrial cells during menstruation occurs in 
most women with patent tubes. Implications of the results for the relation between 
retrograde menstruation, endometriosis, and infertility are discussed. 
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Introduction 
The histogenesis of endometriosis is classically explained by the endometrial 
implantation theory of Sampson [1] as being a consequence of retrograde 
seeding of endometrial cells during menstruation. Initially, this theory was 
questioned on the basis that retrograde menstruation was supposed to be a rare 
phenomenon [2]. Polishuk and Sharf [3], performing culdoscopy during the 
menstrual period, found blood-stained peritoneal fluid (PF) in 50% of the patients. 
Blumenkrantz ef al. [4] observed the occurrence of blood contaminated dialysate 
in 9 out of 11 patients undergoing peritoneal dialysis during their menstrual 
period. Recently, a systematic study of Halme ef a/. [5] indicated that retrograde 
menstruation is a common and physiological event in menstruating women with 
patent tubes. However, the occurrence of red blood cells in PF during 
menstruation does not necessarily correlate with retrograde transport of viable 
endometrial cells. Studies analyzing the incidence of endometrial cells in PF are 
conflicting, the incidence varying from 0% to 59% [6-11]. All reports in which 
endometrial tissue was identified in PF used cytological and/or cell block analyses 
[6,7,9]. In contrast to these methods of analysis, by culturing the cell pellet of PF 
only those endometrial cells will be recognized that have the capacity to adhere 
and proliferate. These cell properties are implied by the endometrial implantation 
theory. Using the culture technique, we could not identify adhering and 
proliferating endometrial cells in any of 115 PF samples obtained during the late 
follicular phase [8]. 
The purpose of the present study was to estimate the present endometrial 
epithelial cells in PF obtained during the early follicular phase (cycle day 1 to 7), 
capable of adherence and proliferation in vitro. 
Materials and methods 
Patients 
Twenty-five women for whom a diagnostic laparoscopy was planned as part of 
infertility investigation consented to participate in the study. The duration of 
infertility was at least 18 months. All women had a regular and ovulatory cycle (26 
to 30 days) without medication, based on basal body temperature curve and 
serum progesterone levels, and had patent tubes without suspicion of pelvic 
adhesions at hysterosalpingography, performed 3 to 6 months earlier. A male 
factor as a possible explanation for infertility existed in 10 couples (count 
<20x106/mL, and/or motility <60%, and/or normal morphology <60%). ТЬе 
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remaining couples had normal semen analyses and positive postcoital tests (>5 
propulsive spermatozoa per high power field). Laparoscopy was planned during 
the early follicular phase (cycle day 1 to 7) based on previous cycle lengths. 
Laparoscopy procedure 
In all cases prophylactic antibiotics were given peroperatively. At laparoscopy 
PF present in the pouch of Douglas was aspirated using the double-puncture 
technique. Under direct visualization ovaries, tubes and pouch of Douglas were 
washed with 20 mL 0.9% NaCI which was again aspirated. Both samples were 
heparinized, kept at ^ C , and brought into tissue culture within 45 minutes. When 
endometriosis was identified, it was staged according to the revised American 
Fertility Society classification [12]. 
Culture preparation 
The complete fluid samples (PF and pelvic peritoneal washing) were 
centrifuged at 200 χ g for 10 minutes. Both cell pellets were then combined and 
resuspended in 4 mL of culture medium consisting of medium RPMI 1640 with 
sodium bicarbonate and HEPES (Dutch modification, GIBCO-Europe, Paisley, 
Scotland), supplemented with 15% fetal bovine serum, 100 U/mL penicillin, and 
100 μg/rг\L streptomycin. This culture medium was arbitrarily chosen because of 
excellent growth conditions for all cell lines used in our laboratory. The 
suspensions were incubated in plastic tissue culture flasks (Costar, Cambridge, 
MA) at 370C in a humidified atmosphere of 5% C02 in air. The medium was 
changed daily. Details of the culture technique have been described previously 
[10]. 
Evaluation of cultures 
Endometrial epithelial cells in culture give rise to characteristic tadpole-shaped 
cells, which during proliferation curl around each other in a whorling pattern 
forming epithelioid colonies [8,10,13]. Therefore, each developing endometrial 
epithelial cell colony in culture represents one or a small cluster of epithelial cells 
initially present in PF and capable of adherence and proliferation. After 7 days the 
cultures were initially screened for the presence of these endometrial epithelial cell 
colonies by phase contrast microscopy. The colonies were further identified by 
their immunoreactivity with the monoclonal antibody (MAb) BW 495/36 using the 
immunoperoxidase technique as described previously [13]. Briefly, the cultures 
were fixed in cold methanol (-20oC) for 1 to 2 minutes. Cells were incubated with 
MAb BW 495/36 for 45 minutes at room temperature. After repeated washing with 
phosphate buffered saline (PBS) containing 0.05% Tween-20, a peroxidase 
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conjugated rabbit antimouse immunoglobulin (DAKO-lmmunoglobulins Ltd., 
Copenhagen, Denmark) was applied as second antibody and incubated for 30 
minutes in a moist chamber. After repeated washing with PBS containing 0.05% 
Tween-20, diaminobenzidine substrate solution was applied. The MAb BW 495/36 
is directed against a 200 kilo-Dalton glycoprotein in epithelial cell types [14]. In a 
recent study we have shown that this epithelial marker stains positively with all 
endometrial epithelial cells both on cryostat sections as well as on cell cultures 
and independent of the phase of the cycle during which the tissues/cells are 
obtained [13]. In contrast it was shown that normal mesothelial cells on cryostat 
sections (ovarian epithelial lining) as well as on cell cultures (mesothelial cells 
present in PF) do not react with MAb BW 495/36, the results regarding cultured 
mesothelial cells being consistent with previous observations [15]. 
Since significant interindividual differences in number of developing endometrial 
epithelial cell colonies were not expected in anticipation, an additional experiment 
was performed afterwards, in which the reproducibility of the method used to 
count the number of endometrial epithelial cell colonies was evaluated. Twenty-
five PF samples, obtained after uterine-tubal flushing with 0.9% NaCI, were equally 
divided in two parts before starting culture preparation. A good correlation was 
found between the number of cell colonies counted in both cultures of each 
sample after 7 days incubation (Figure 3.1). 
NUMBER OF EECC SAMPLE 1 
Figure 3.1. 
Correlation in number of developing 
endometrial epithelial cell colonies after 
dividing each PF sample equally in two 
parts (Sample 1 and 2) before starting 
culture preparation. In three PF samples, 
both parts contained >100 epithelial cell 
colonies. Nonparametric analysis with the 
Spearman rank-order test revealed a 
significant correlation (r=0.96). 
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Statistical evaluation 
Statistical analysis were made with the chi-square method, the unpaired 
Student's f-test, and the Mann-Whitney U test where appropriate. 
Results 
Within the selected group of 25 women, laparoscopy in one woman was 
canceled since menstruation occurred later than predicted and pregnancy could 
not be excluded. At laparoscopy three women showed adhesions, although not 
interfering with adequate sampling of the PF. Endometriosis was identified in 12 
women (50%), 11 stage I, and 1 stage III (endometrioma in left ovary, no 
adhesions). Initially, statistical evaluation was performed by dividing the patient 
samples on the basis of the presence of endometriosis: (1) women with 
endometriosis (n=12), and (2) women without endometriosis (n=12). Statistical 
analysis was repeated, dividing the patient samples on the basis of mechanical 
and/or male infertility factors: (1) women with mechanical and/or male infertility 
factors (n=13)> and (2) women without mechanical and male infertility factors 
(n=11). 
Peritoneal fluid 
The collected PF volume varied from 1.0 to 29.0 mL (mean ± SD = 8.2 ± 6.9 
mL). No significant correlations were noted with cycle day of collection, presence 
or absence of endometriosis (7.8 ± 6.9 versus 8.5 ± 7.3 mL), and presence or 
absence of mechanical and/or male infertility factors (9.1 ± 8.3 versus 7.1 ± 5.0 
mL). All PF samples except one were blood contaminated. 
Endometrial epithelial cell colonies 
The number of cells / endometrial epithelial cell colony varied from 5 to > 50 
cells, although cell colonies larger than 20 cells were rare. In none of the cultures 
was confluency of the cell layer reached after 1 week incubation. In 19 women 
(79%) endometrial epithelial cell colonies were identified in culture. The incidence 
in women with endometriosis was 8 out of 12 (67%), in women without 
endometriosis 11 out of 12 (92%), the difference was not significant. The number 
of developing cell colonies / PF sample varied from 0 to >100, in one sample 
>200 endometrial epithelial cell colonies were present. The number of cell 
colonies did not correlate with PF volume and cycle day (Figure 3.2). 
Furthermore, no significant difference in number of cell colonies was observed 
between women with and without endometriosis (Figure 3.3). However, when 
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Figure 3.2. Number of developing endometrial epithelial cell colonies versus PF volume, and 
cycle day. Circles, with endometriosis; squares, without endometriosis. 
women were grouped according to the presence or absence of mechanical 
and/or male factors as a possible explanation for infertility, a significantly 
increased number of developing cell colonies was found in the group in which 
mechanical and male infertility factors were excluded (Figure 3.4, P=0.01). 
Besides endometriosis in 6 out of 11 of these women (55%), no other explanation 
for the infertility was demonstrated. In the group of women with mechanical 
and/or male infertility factors, endometriosis was found in 6 out of 13 (46%). 
Discussion 
The endometrial implantation theory assumes that during menstruation 
endometrial cells that have the capacity to adhere and proliferate are retrogradely 
seeded. Reports documenting the incidence of viable endometrial cells in PF are 
conflicting. Cytological preparation of PF samples, obtained during different 
phases of the cycle, revealed the presence of endometrial tissue in varying 
numbers of patients (Table 3.1) [6,7,9,11]. Whereas Koninckx et al. [6] and 
Bartosik eí al. [9] observed endometrial tissue in PF as frequently in women with 
endometriosis as in those without, Badawy ef al. [7] identified endometrial 
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squares, without endometriosis. 
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Table 3.1. Review literature on the incidence of endometrial cells in peritoneal fluid 
authors 
Konmckx 
et al. [6¡ 
Blumenkrantz 
et al. ¡4} 
Badawy 
et al. [7] 
Willemsen 
et al. [8] 
Bartosik 
et al. [9] 
Kulenthran 
et al. [11] 
Present study 
analyzing 
method 
cytology 
not 
specified 
cytology 
culture 
cytology 
cell block 
cytology 
culture 
cycle 
phase 
proliferative 
luteal (day 14-20) 
luteal (day 21-25) 
menstruation 
not specified 
late proliferative 
not specified 
day 8-20 
day 1-7 
endometriosis 
present 
absent 
present 
absent 
present 
absent 
not specified 
present 
absent 
not specified 
present 
absent 
not specified 
present 
absent 
PF 
samples 
No. 
4 
13 
17 
17 
16 
16 
3 
45 
57A 
115 
32 
9 
21 
12 
12 
identification 
of endometrial 
cells (%) 
75 
54 
53 
53 
25 
31 
0 
31 
10 
0 
19 
11 
0 
69 
92 
including women with occluded tubes 
tissue more frequently in women with endometriosis than without endometriosis. 
They suggested that fewer endometrial cells were retrogradely seeded in some of 
the women without endometriosis. However, women with tubal obstruction were 
not excluded, which also can explain the observed difference. By culturing the 
cell pellet from preovulatory obtained PF before uterine-tubal irrigation, we could 
not identify adhering and proliferating endometrial cells in any of 115 cultures, 
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whereas after uterine-tubal irrigation proliferating endometrial epithelial cells were 
present in 67% of the cultures [8]. This discrepancy with reports in which 
cytological analysis was used for the identification of endometrial tissue may be 
explained in part by a difference in cycle phase during which the PF was 
obtained. Koninckx et al. [6] found endometrial tissue most frequently during the 
proliferative phase, the incidence decreasing progressively during the luteal 
phase. However, in the late luteal phase they still identified endometrial tissue in 
28% of the PF samples, both in women with and without endometriosis. 
Another explanation for the discrepancy between cytological and culture 
analysis of PF could be that by cytological analysis mainly large intact glandular 
structures are observed [9], whereas by culturing the cell pellet single cells 
and/or small cell clusters give rise to the developing endometrial epithelial cell 
colonies. In fact, in previous studies we have observed intact glandular structures 
in cultures of PF obtained during the late follicular phase that, since they did not 
adhere to the surface of the culture flask, were removed when changing the 
culture medium [16]. This inability to adhere and/or proliferate may also account 
for the fact that the endometrial glandular structures observed during late 
proliferative and luteal phase were still present in PF. When retrogradely seeded 
during menstruation, one would expect them to have already attached to the 
peritoneum, when indeed these cells are responsible for the development of 
endometriosis. Therefore, with regard to the endometrial implantation theory, 
these glandular structures are likely to be less important for the development of 
endometriosis. The present study focused on PF obtained during the early 
follicular phase and clearly indicates that in most women with patent tubes (79%) 
viable endometrial epithelial cells with the capacity to adhere and proliferate are 
present. There is no significant difference in incidence between women with and 
without endometriosis. 
The number of developing endometrial epithelial cell colonies showed a large 
variation (0 to >100 / PF sample). Numerous factors, for which in this study no 
standardization was performed, may have influence on the ability to culture cells, 
e.g. presence of cells capable of elaborating "growth factors" (macrophages, 
fibroblasts, lymfocytes), and erythrocytes (hemoglobin, iron) known to enhance 
the growth of several types of cells. However, it is more likely that these factors 
influence the size of the developing cell colonies (number of cells) rather than the 
number of cell colonies. Since each cell colony develops out of one or a small 
cluster of endometrial epithelial cells, the most significant factor causing the large 
interindividual variation in number of developing cell colonies probably is the 
number of endometrial epithelial cells present in the PF and capable of 
adherence and proliferation in vitro. It has been suggested that an altered 
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immune response is an additional factor by which elimination of retrogradely 
seeded endometrial cells is delayed and endometriosis can develop [17-18]. 
Within this concept, the number of retrogradely seeded endometrial cells with 
adhering and proliferating properties can also be important, when exceeding the 
capacity of the immune system. The present results did not show a distinction in 
number of developing endometrial epithelial cell colonies between women with 
minimal and without endometriosis. Only one woman with moderate 
endometriosis participated in the study allowing no conclusions to be drawn with 
regard to women with more extensive endometriosis. 
An interesting finding was the demonstrated association between higher 
numbers of developing endometrial epithelial cell colonies in culture and the 
absence of mechanical and male infertility factors. All women in the present study 
had normal endocrinological profiles of their menstrual cycle. Previous reports, 
focusing on number and activity of peritoneal macrophages, and their role in 
infertility related to endometriosis, disagree when comparing women with and 
without endometriosis [19-25]. Awadalla et al. [23] suggested that the populations 
studied in several reports were probably not homogeneous. Olive et al. [24,25] 
using multiregression analysis, found the best correlation with elevated number of 
peritoneal macrophages in women having infertility without mechanical or 
endocrinological infertility factors, of which women with mild endometriosis were a 
subgroup. In this population, couples with male infertility factors were excluded. 
They suggested that elevated macrophages and leucocytosis (intraperitoneal 
inflammation), which can cause infertility, is a response by some women to 
retrograde menstruation, rather than being a response to the occasional 
consequence of retrograde menstruation (endometriosis). The present data are 
consistent with this concept. Although it remains to be proven that the number of 
developing endometrial epithelial cell colonies is correlated with the total amount 
of retrogradely seeded cells, it may well be that in some women a significant 
number of endometrial cells retrogradely seeded during menstruation cause an 
intraperitoneal imflammation, which can lead to infertility regardless of the 
presence or absence of endometriosis. 
In conclusion, during menstruation viable endometrial epithelial cells, which 
adhere and proliferate in vitro, can be identified in the PF of the majority of 
women with patent tubes, ft was shown that a higher number of developing 
endometrial epithelial cell colonies in culture was correlated with infertility in the 
absence of mechanical and male infertility factors, independent of the presence or 
absence of endometriosis. 
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Chapter 4 
Oestradiol-17/з and progesterone level changes in peritoneal 
fluid around the time of ovulation. 
R.F.P.M. Kruitwagen, H.A.B. Janssen-Caspers, J.W. Wladimiroff, R. Schats, 
F.H. de Jong, A.C. Drogendijk 
(British Journal of Obstetrics and Gynaecology 94:548-553, 1987) 
Study performed in the Academic Hospital Rotterdam-Dijzigt of the Erasmus 
University. 
Abstract 
In 15 women, peritoneal fluid (PF) was obtained by either culdocentesis 
(n=20) or laparoscopy (n=3)
>
 before (n=9) and after (n=14) ovulation. 
Ultrasound was used for ovulation detection. Before ovulation the mean 
oestradiol-17ß (E2) level in plasma and PF was not essentially different; the mean 
progesterone (P) level was significantly higher in PF. After ovulation both the 
mean Έ? and Ρ levels were significantly higher in PF than in plasma. In PF, there 
was a wide distribution of individual E2 values before and after ovulation; no 
significant difference existed between the mean pre- and postovulatory E2 level. 
More consistent changes were seen in PF Ρ levels; the mean level was 
significantly higher after ovulation. In three subjects, a low postovulatory Ρ level in 
PF was associated with a cystic luteal structure observed by ultrasound, 
suggesting a reduced leakage of fluid from the ovulation stigma. 
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Introduction 
There are several studies of changes in steroid hormone levels in peritoneal 
fluid (PF) around the time of ovulation [1-3]. Authors differ in their assessment of 
the value of these changes for the retrospective diagnosis of ovulation or the 
occurrence of a luteinized unruptured follicle (LUF) [4-7]. A basic deficiency in all 
these studies is that the criterion of ovulation, if determined at all, was an 
ovulation stigma seen at laparoscopy, which in itself has been demonstrated to 
be inaccurate [8-9]. Ultrasound has now been accepted as a reliable method for 
establishing ovulation [10-12]. 
The object of the present study was to provide further information on steroid 
hormone level changes in PF around the time of ovulation with the use of 
ultrasound for ovulation detection. 
Subjects and Methods 
A total of 15 women consented to participation in the study. The study itself 
was approved by the ethics review board. There were eight women with 
unexplained infertility, four infertile women with endometriosis, diagnosed by 
observing endometrial implants at laparoscopy and classified as mild according 
to the criteria of Acosta eí al. [13], and three women with proven fertility who 
requested reversal of sterilization. All had regular biphasic menstrual cycles. 
Ovulation was detected by daily ultrasound measurements of follicular size. 
These were started 3 to 4 days before the expected date of ovulation predicted 
from basal body temperature with or without ultrasound follicular monitoring in 
previous cycles. Ultrasound examinations were made with a Pie-Data 900 real-
time sector scanner with a 3.5 MHz transducer; a calibrated sound velocity of 
1540 m/s was used. The follicles were measured in three dimensions with 
electronic calipers. In the parasagittal plane the largest longitudinal and antero-
posterior diameter and in the transversal plane, the largest horizontal diameter 
was measured. From these three diameters the mean was calculated. Ovulation 
was defined as a decrease in mean follicular diameter by at least 5 mm or the 
complete disappearance of the follicle. 
It was planned that each of the 12 infertile patients should provide one pre-
and postovulatory PF sample, collected in two consecutive cycles by 
culdocentesis, using the Cupido system (Medical Developments and Technology, 
The Netherlands) [14]. This consists of a needle guidance system which is 
introduced into the posterior fornix. A vacuum is applied for attachment to the 
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vaginal wall. A needle covered by a teflon catheter is subsequently introduced 
through the needle-guidance system into the cul-de-sac. Following withdrawal of 
the needle, PF is collected via the catheter. 
The primary object for the pre-ovulatory sampling of PF was to compare the 
value of the spermatozoa-recovery with the postcoital test. The PF sample was 
obtained as near as possible to the day of ovulation, as estimated from 
ultrasound measurements of follicular size and from the cervical mucus. After 
collection of PF, daily ultrasound scans were continued until the occurrence and 
timing of ovulation was confirmed. The primary object of the postovulatory 
sampling of PF was to compare the value of steroid hormone measurements in 
this fluid with ultrasound for the diagnosis of a LUF. For the same purpose, in 
three women requesting reversal of sterilization, a laparoscopy was planned to 
follow ovulation. However, ovulation occurred later than predicted and pre-
ovulatory fluid was collected. All three patients consented to culdocentesis for PF 
collection after ovulation. 
All postovulatory PF samples were collected within 24 hours after ovulation 
was detected by daily ultrasound scans. A final ultrasound scan was performed 
immediately before the puncture procedure in order to estimate the amount of 
free fluid in the cul-de-sac. 
Plasma was obtained at the time of every PF collection. All PF and plasma 
samples were centrifuged for 10 min at 2500 r/min and the supernatant fluid was 
then frozen within 30 min after collection. To avoid the possibility of extensive 
contamination of the PF with blood only those PF samples which after 
centrifugation had a cell layer of less than 5% were used. 
Concentrations of progesterone (P) and oestradiol-17/S (E2) in PF and plasma 
were estimated by radioimmunoassay, using the method described by de Jong et 
al. [15] and with kits provided by EIR (Würenlingen, Switzerland) respectively. The 
intra- and interassay standard deviation for these estimations were 7.4% and 11% 
for E2 and 11.2% and 13.7% for P. 
Paired statistical analysis of the hormone data in plasma and PF used the 
Wilcoxon's rank sum test. Statistical analysis of the hormone data in PF alone 
used the Mann-Whitney IMest. 
Table 4.1. Hormonal data from 15 women of nine pre-ovulatory and 14 post-ovulatory plasma and peritoneal fluid samples 
pre-ovulatory sampling postovulatory sampling 
patient diagnosis* PF E2 (pmol/L) Ρ (nmol/L) PF Ег (pmol/L) Ρ (nmol/L) 
number volume volume 
(mL) PF plasma ratio PF plasma ratio (mL) PF plasma ratio PF plasma ratio 
1 
2 
3 
4 
5 
6 
7 
a 
9 
10 
11 
12 
13 
14 
15 
Ρ 
Ρ 
Ρ 
υ 
и 
и 
и 
и 
и 
υ 
и 
E 
E 
E 
E 
80 
40 
75 
12 0 
110 
40 
30 
50 
35 
2010 
732 
2028 
1401 
1072 
172 
325 
477 
383 
1276 
763 
552 
1325 
945 
669 
755 
384 
803 
16 
10 
37 
1 1 
1 1 
03 
04 
12 
05 
60 
21 
14 1 
68 
79 
47 
46 
51 
53 
28 
18 
35 
32 
33 
48 
32 
40 
45 
21 
12 
40 
21 
24 
10 
14 
13 
12 
80 
40 
18 0 
35 0 
30 0 
40 
15 0 
15 0 
80 
70 
10 0 
130 
70 
80 
3927 
750 
1398 
981 
288 
3333 
498 
6534 
1269 
3507 
4341 
3132 
3387 
621 
157 
430 
404 
269 
305 
161 
791 
666 
396 
142 
207 
350 
193 
293 
25 0 
17 
35 
36 
09 
20 7 
06 
10 8 
32 
24 7 
210 
89 
176 
22 
551 
28 
14 
166 
168 
713 
5 
2225 
154 
586 
370 
578 
687 
278 
12 6 
12 6 
30 
85 
12 2 
10 2 
50 
173 
96 
34 
82 
57 
11 6 
75 
43 8 
22 
50 
19 6 
13 8 
70 0 
1 1 
128 6 
16 1 
172 3 
45 2 
101 5 
59 2 
371 
* Ρ = proven fertility 
U= unexplained infertility 
E= endometriosis 
Results 
In the 27 cycles (12 patients with two cycles and three patients with one cycle) 
included in this study we found normal mid-luteal plasma Ρ levels (>25 nmol/l) 
and normal luteal phase durations (>12 days from the day of ovulation) (Table 
4.1). Culdocentesis failed to obtain PF on two occasions (no. 3 postovulatory 
sample, no. 14 pre-ovulatory sample). In six women (no. 2, 3, 4, 5, 6 and 15) 
ovulation occurred within 24 hours (h) after pre-ovulatory collection of PF and in 
three women (no. 1, 7 and 12) within 24 to 48 h. In five women (no. 8, 9, 10, 11 
and 13) no pre-ovulatory PF sample was collected, because ovulation had 
already occurred 0 to 24 h before the puncture procedure. In all, nine pre­
ovulatory and 14 postovulatory PF and plasma samples were available for further 
analysis. 
In three women (no. 2, 4 and 8) a cystic luteal structure was observed by 
ultrasound at the time of postovulatory culdocentesis. The mean diameter of this 
echo-free structure was nearly equal to that of the pre-ovulatory follicle although 
before this observation there had been an ovulation according to our standards 
(a reduction of the follicular mean diameter of at least 5 mm). 
Comparison of steroid hormone levels in plasma and PF (Figure 4.1) 
Before ovulation (nine cycles) there was no significant difference between the 
mean E2 level in plasma (830 pmol/L, range 384-1325 pmol/L) and PF (956 
pmol/L, range 172-2028 pmol/L), the PF/plasma ratio of E2 was 1.2 (range 0.3-
3.7). After ovulation (14 cycles) the mean E2 level in plama (336 pmol/L, range 
142-791 pmol/L) was significantly lower (P<0.01) that that in PF (2426 pmol/L, 
range 288-6534 pmol/L), the mean PF/plasma ratio of E2 was 10.3 (range 0.6-
25.0). 
Before ovulation (nine cycles) the mean Ρ level in PF (6.3 nmol/L, range 2.1-
14.1 nmol/L) was significantly higher (P<0.02) than that in plasma (3.5 nmol/L, 
range 1.8-4.8 nmol/L), the mean PF/plasma ratio of Ρ was 1.9 (range 1.0-4.0). 
After ovulation (14 cycles) this difference in mean Ρ level between PF (446.4 
nmol/L, range 5-2225 nmol/L) and plasma (9.1 nmol/L, range 3.0-17.3 nmol/L) 
became much more pronounced (P<0.01), the mean PF/plasma ratio of Ρ being 
51.1 (range 1.1-172.3). 
Comparison of steroid hormone levels in PF (Figure 4.1) 
There was a wide distribution of individual E2 values before as well as after 
ovulation with an overlap between both groups of values (before ovulation: 172-
2028 pmol/L; after ovulation: 288-6534 pmol/L). There was no statistically 
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Figure 4.1. Oestradiol-17ß and progesterone levels m plasma (circles) and peritoneal fluid 
(squares) on a log scale Horizontal lines represent the mean concentration 
significant difference between the mean pre- and postovulatory E2 level in PF. 
The mean PF Ρ level was significantly higher after ovulation (P<0 01) than that 
before ovulation Before ovulation, Ρ levels in PF were low (<15 nmol/L) whereas 
after ovulation there was a wide distribution of individual values (5-2225 nmol/L). 
Discussion 
Our data relating mean E2 and Ρ levels in plasma and PF shortly before and 
after ovulation are in agreement with previous reports [1-3] Before ovulation the 
mean E2 levels in plasma and PF are not essentially different, whereas the Ρ level 
in PF is significantly higher that that in plamsa After ovulation both the mean Ez 
and Ρ levels in PF are significantly higher that the values in plasma, with the 
mean ratio between PF and plasma being 10 3 for E2 and 51 1 for Ρ 
A marked increase in the mean Ρ level in PF after ovulation has been reported 
[1-3], and this was confirmed in the present study. The three women with 
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relatively low postovulatory Ρ levels (no. 2, 4 and 8), resulting in a small overlap 
with the pre-ovulatory values, each, by ultrasound, had a luteal structure with 
nearly the same diameter as the pre-ovulatory follicle at the time of the 
culdocentesis. In these women, after ovulation, there may have been re-
epithelialization of the stigma so that leakage of fluid (with a high Ρ concentration) 
was minimal [8]. The secretions of the early corpus luteum, which are usually 
directed towards the peritoneal cavity [2] are retained and result in the follicle-like 
structure which can be observed by ultrasound. In a similar study, Zorn ef a/. [3] 
did not observe such low postovulatory Ρ levels in PF. Also in contrast to Zorn ef 
al. [3], we found no significant difference between the mean E2 levels in PF 
before and after ovulation. The explanation for these differences could be two­
fold: first, Zorn ef al. [3] detected ovulation by the relatively unreliable method of 
laparoscopic demonstration of the ovulation stigma and second, in both studies a 
limited number of pre- and postovulatory PF samples was examined. 
In two subjects (no. 1 and 2), we were able to compare pre- and 
postovulatory PF samples obtained during the same cycle. This has been 
described only once before by Bernardus ef al. [16], who compared PF samples 
obtained from one patient before and after mechanical rupture of a LUF at 
laparoscopy; after rupture there was a marked rise in Ea and Ρ levels resulting in 
much higher PF to plasma ratios for both hormones. In the present study, in one 
subject (no. 1) both the E2 and Ρ ratio in PF to plasma also showed a marked 
rise (1.6 to 25.0 and 2.1 to 43.8, respectively). In the other subject (no. 2), 
however, both ratios remained low after ovulation (1.0 to 1.7 and 1.2 to 2.2, 
respectively), and this was associated with the development of a cystic luteal 
structure. 
The detection of ovulation or of LUF by steroid hormone assays of PF is 
based on differences in hormone levels before and after ovulation. We conclude 
that E2 determination is of limited value, since both pre- and postovulatory values 
show a wide distribution. More consistent changes are seen in PF Ρ 
concentrations before and after ovulation. However, low postovulatory Ρ levels in 
PF may result from reduced leakage of fluid from the ovulation stigma. 
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Chapter 5 
Retrograde seeding of endometrial epithelial cells by uterine-
tubal flushing 
R.F.PM Kruitwagen, LG. Poels, W.N.P. Willemsen, P.H.K. Jap, C.M.G. Thomas, 
R. Rolland 
(Fertility and Sterility: in press) 
Abstract 
Objective: To estimate the amount of endometrial epithelial cells in peritoneal fluid 
(PF) after uterine-tubal flushing (40 mL) throughout the menstrual cycle. 
Design: We cultured the cell pellet of flush medium present in the peritoneal 
cavity. 
Setting: University Hospital Nijmegen (The Netherlands). 
Patients: Ninety-two women with various infertility related factors. Inclusion 
criteria: (1) ovulatory cycle, (2) patent tubes, (3) no adhesions. 
Interventions: None. 
Main outcome measure(s): The number of developing epithelial cell colonies 
were counted after 7 days. We started to record the amount of flush medium 
recovered during the study. 
Results: The amount of flush medium recovered was positively correlated with 
the presence of endometriosis (P=0.017). Endometrial epithelial cells were 
identified in Θ5 flush media (92%). The number of epithelial cell colonies varied 
from 0 to 100 or more, and was higher when flushing was performed during the 
early follicular phase (P<0.01). High estradiol-17/? and progesterone levels in 
culture medium did not change the number of developing cell colonies. 
Methylene blue significantly reduced the number of cell colonies (P=0.002). 
Conclusions: Uterine-tubal flushing results in varying numbers of endometrial 
epithelial cells in PF. Methylene blue adversely affects the growth potential of 
these cells. 
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Introduction 
The exact prevalence of endometriosis is unknown and varies in different 
patient populations from <1% to as high as 50%, the highest incidence being 
reported in women with fertility problems [1]. In our clinic, at laparoscopy for 
infertility work-up, endometriosis is noted in approximately 45% [2]. Classically, 
the histogenesis of endometriosis is explained by the endometrial implantation 
theory of Sampson as being a consequence of retrograde menstruation [3]. 
Lymfatic and vascular dissemination of endometrial cells has also been described 
[4]. An iatrogenic contribution to the development of endometriosis by means of 
uterine-tubal flushing was suggested by several authors who demonstrated the 
presence of endometrial tissue fragments and cells in peritoneal fluid (PF) after 
flushing of the uterus and tubes [5-9]. Bartosik ef al. [6] reported a significantly 
higher incidence of endometrial tissue in PF after uterine-tubal flushing in women 
with endometriosis versus women without endometriosis. This observation was 
consistent with the theory that women with endometriosis (and unexplained 
infertility) may have an increased amount of retrograde menstruation [10,11]. 
However, the amount of refluxed endometrial cells was not quantified in any of 
these reports. Recently, we have introduced a technique by which the amount of 
endometrial epithelial cells in PF with adhering and proliferating properties can be 
estimated [12]. The cell pellet of PF, obtained during the early follicular phase 
(cycle day 1 to 7) of the menstrual cycle, was brought into culture, and the 
number of developing endometrial epithelial cell colonies were counted. Each cell 
colony represents one or a small cluster of epithelial cells present in PF capable 
of adherence and proliferation in vitro. A large interindividual variation in number 
of developing endometrial epithelial cell colonies was found. 
The object of the present study was to provide information on the amount of 
refluxed endometrial epithelial cells with adhering and proliferating properties after 
uterine-tubal flushing. Several factors (cycle phase, endometriosis, unexplained 
infertility) that may be associated with a larger amount of retrogradely transported 
endometrial cells were evaluated. For this purpose, the amount of flush medium 
recovered from the peritoneal cavity was also recorded. Furthermore, we 
investigated the influence of high estradiol-17ß (Е
г
) and progesterone (P) 
concentrations in culture medium comparable to postovulatory levels in PF and of 
methylene blue on the in vitro growth potential of endometrial epithelial cells. 
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Materials and Methods 
Patients 
A total of 92 women in whom a diagnostic laparoscopy was performed as 
part of their infertility investigation participated in the study. Inclusion criteria were: 
(1) a regular and ovulatory cycle based on basal body temperature (BBT) curves 
and serum Ρ concentrations compatible with postovulatory states; (2) patent 
tubes without suspicion of pelvic adhesions at hysterosalpingography performed 
3 to 6 months earlier; and (3) no adhesions at laparoscopy. All women gave 
informed consent. 
Laparoscopy was planned during various phases of the menstrual cycle based 
on previous cycle lenghts and BBT curves. When laparoscopy was performed 
during the early follicular phase, prophylactic antibiotics were given peroperatively 
because theoretically bacterial contamination of the cervix may be more 
pronounced during menstruation. At laparoscopy a blood sample was taken for Ρ 
measurement, which was used retrospectively for a more precise cycle phase 
determination (early follicular phase: cycle day 1 to 7; midfollicular phase: cycle 
day >7 and serum Ρ <2 nmol/L; periovulatory phase: cycle day >12 and serum 
Ρ >2 and <10 nmol/L; luteal phase: cycle day >12 and serum Ρ >10 nmol/L). 
Women in whom the laparoscopy was planned during the periovulatory and luteal 
phase (n=35) were advised to use mechanical contraconceptives during that 
cycle. 
At the time of laparoscopy, the following variables were recorded for each 
woman: (1) nulliparous or multiparous; (2) presence or absence of male and/or 
cervical mucus infertility factor; (3) cycle phase (early follicular, midfollicular, 
periovulatory, or luteal phase); and (4) presence or absence of endometriosis. 
Because multiparous women may have a lacerated cervix resulting in 
increased leakage of flush medium during Pertubation, multiparity versus 
nulliparity was introduced as a variable. As to the male and/or cervical mucus 
infertility factor, a normal semen analysis was defined as a sperm count of 
>20x10e/mL, with >60% good motility and >60% normal morphology. A normal 
postcoital test was defined as >5 propulsive spermatozoa per high power field. 
Endometriosis was staged according to the revised American Fertility Society 
classification [13]. 
Tubal lavage 
Laparoscopy was performed using the double-puncture technique. Peritoneal 
fluid present in the pouch of Douglas was aspirated. Following this, tubal lavage 
was performed by injecting exactly 40 mL of 0.9% NaCI through an uterine 
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cannula into the uterine cavity. Flush medium entering the peritoneal cavity was 
aspirated, kept at 40C, and brought into tissue culture within 45 minutes. Except 
for the initial 15 samples, the amount of flush medium recovered was recorded. 
Culture preparation 
Flush samples were centrifuged at 200 χ g for 10 minutes. The cell pellets 
were brought into culture according to the method as described previously [8]. 
Briefly, the cell pellets were resuspended in 4 mL of culture medium RPMI 1640 
with sodium bicarbonate and HEPES (Dutch modification, GIBCO-Europe, Paisley, 
Scotland), supplemented with 15% fetal bovine serum, 100 U/mL penicillin, and 
100 μg/mL· streptomycin. The cultures were incubated in plastic tissue culture 
flasks (Costar, Cambridge, MA) at 370C in a humidified atmosphere of 5% C0 2 in 
air. The medium was changed daily. 
The effects of hormones and methylene blue on the growth potential of 
endometrial epithelial cells were studied by dividing flush samples into two equal 
parts. Thereafter both samples were centrifuged and treated according to the 
condition tested. 
(1) Of 20 flush samples, one cell pellet was resuspended in 0.9% NaCI, and the 
other one in 0.9% NaCI containing 0.01% methylene blue, followed by 
centrrfugation at 200 χ g for 10 minutes. The concentration of 0.01% 
methylene blue was chosen arbitrarily because we use this concentration 
routinely for tubal patency testing at laparoscopy. Further treatment of both 
cell pellets occurred according to standard procedures; therefore, the 
duration of incubation with 0.01% methylene blue solution of one cell pellet 
was only 10 to 11 minutes. 
(2) Of 20 flush samples, treatment of both cell pellets occurred according to 
standard procedures with the restriction that the culture medium of one cell 
pellet was supplemented with 590 nmol/L Ρ and 5800 pmol/L Eg, both levels 
corresponding with high E2 and Ρ levels in PF directly after ovulation [14,15]. 
The culture medium was changed daily. 
We have shown that dividing flush samples into two equal parts is a reliable 
method as demonstrated by a good correlation in number of developing epithelial 
cell colonies in both cultures [12]. 
Assays of Ej and Ρ 
Determination of Eg in culture medium and Ρ levels in both serum and culture 
medium were performed with a specific charcoal radioimmunoassay (RIA) 
according to Thomas ef a/. [16]. This assay included extraction with diethylether. 
The intra-assay and interassay coefficients of variation for means of duplicate 
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determinations were 4.3% and 7.9% in the case of Ej after 78 consecutive assay 
runs (mean of serum pool 820 pmol/L), and 4.1% and 9.1% with Ρ after 36 assay 
runs and a pool mean of 39 nmol/L. 
Evaluation of cultures 
In cultures of cell suspensions of PF after uterine-tubal irrigation, endometrial 
epithelial cells give rise to characteristic tadpole-shaped cells, which in larger 
colonies curl around each other in a whorling pattern [7,8]. After 7 days the 
cultures were screened for the presence of endometrial epithelial cell colonies as 
previously described [12]. Briefly, the cultures were fixed in methanol at -20oC. 
With the use of the monoclonal antibody BW 495/36 the identification of these 
endometrial epithelial cell colonies was facilitated, and the number of epithelial cell 
colonies was counted [17]. Of those samples used to investigate the influence of 
hormones and methylene blue, the number of epithelial cell colonies in the control 
culture was doubled when comparing the number of developing epithelial cell 
colonies interindividually. 
Statistics 
Standard nonparametric statistics (Wilcoxon's test, Kruskal-Wallis test) were 
applied to investigate univariate the relations between flush medium recovered 
and number of endometrial epithelial cell colonies, and other variables studied 
(parity, cycle phase, male and/or cervical mucus infertility factor, and 
endometriosis). To determine simultaneously the contribution by each of these 
variables on the amount of flush medium aspirated and the number of developing 
endometrial epithelial cell colonies, multiple regression analyses were performed. 
For this purpose, the amount of flush medium recovered and the number of 
epithelial cell colonies were logarithmically transformed (to avoid 0 values 1 was 
added). To assess the influence of hormones and methylene blue on the number 
of endometrial epithelial cell colonies, a comparison with the standard procedure 
was performed using the Wilcoxon's test (paired results). 
Results 
Table 5.1 shows the distribution of the four variables studied and the 
corresponding results with regard to the amount of flush medium recovered and 
the number of developing endometrial epithelial cell colonies in vitro. 
Endometriosis was diagnosed in 52 women (48 stage I, 2 stage II, and 2 stage 
III). Especially in those cases in which <10 mL flush-medium was recovered, 
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Table S.I. Distribution of variables studied with regard to flush medium recovered and 
number of developing endometrial epithelial cell colonies among infertile women 
EECC' 
variable women 
flush medium 
recovered (mL) present number 
No (%) P25 • P50 - P75B No (%) P2S-P50-P75a 
nulliparous 
multiparous 
male and/or cervical mucus factor 
no male I cervical mucus factor 
cycle phase 
early follicular 
midfollicular 
penovulatory 
luteal 
endometriosis 
no endometriosis 
80(87 0) 
12 (13 0) 
66 (71 5) 
26 (28 5) 
25(27 0) 
32 (35 0) 
19 (205) 
16 (17 5) 
210-
13 0-
14 5-
2 6 0 · 
24 0 -
Í 9 0 -
12 0-
105-
•28 3-
•19 5-
•233-
• 3 0 0 -
2 9 5 -
2 3 3 -
2 6 0 -
24 0 -
-32 0 
24 0 
- 3 Í 0 
-3 3 5 
32 3 
3 0 8 
32 0 
3 Í 5 
74 (92 5) 
11 (91 5) 
59(89 5) 
26 croo; 
25 croo; 
28(87 5) 
17 (89 5) 
15 (94 0) 
6-
12 
6 -
7 -
Г5· 
3 -
5 -
3 -
Г6-
- re 
гз-
32-
-44 
re-
rr -
7 -
52 
- 4 Í 
38 
• 78 
- roo 
34 
5Г 
20 
52 C56 5; 228-295-320 
40(43 5) 13 5-225-303 
48 (92 5) 7-17-54 
37 C92 5) 5-12-41 
* EECC = endometrial epithelial cell colonies 
B
 percentiles 
Pertubation with a methylene blue solution was necessary afterwards for a definite 
evidence of tubal patency on both sides. 
Flush medium 
The amount of flush medium aspirated from the peritoneal cavity varied from 3 
to 37 mL (median of 27 mL, Figure 51). In some women a high pressure was 
needed for Pertubation, which often was accompanied by cervical leakage of 
fluid There was no correlation between the amount of flush medium recovered 
and cycle phase during which the laparoscopy was performed. No significant 
difference in amount of flush medium was found between nulliparous and 
multiparous women. The amount of flush medium recovered appeared to be 
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Figure 5.1. Volume of flush medium recovered versus number of developing endometrial 
epithelial cell colonies. Circles designate all women with endometriosis, whereas 
squares designate all women without endometriosis. Closed circles and squares 
indicate the samples taken during the early follicular phase of the menstrual cycle. 
significantly larger in women with endometriosis versus women without 
endometriosis (Wilcoxon's test, P=0.007), as wel as in women without a male and 
cervical mucus infertility factor versus women with one of these infertility factors 
(Wilcoxon's test, P=0.007). Multiple regression analysis was used to determine 
simultaneously the contribution by each of the four variables on the amount of 
flush medium recovered (Table 5.2). Only the presence of endometriosis was 
significantly correlated with a larger amount of flush medium recovered (P=0.017). 
The absence of a male and cervical mucus infertility factor nearly reached the 
level of significance (P=0.053). 
Endometrial epithelial cell colonies 
In cultures from 85 of the 92 women (92%) endometrial epithelial cells were 
identified. The number of developing endometrial epithelial cell colonies under 
standard conditions showed a large interindividual variation (0 to 100 or more, 
Figure 5.1). Tbe size of each cell colony after 7 days of culture was mostly 
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Table 5.2. Multiple regression analysis for flush medium recovered and number of developing 
endometrial epithelial cell colonies among infertile women. 
flush medium recovered number of EECCA 
paired variables В valueB SEM В value8 SEM 
multiparae versus 
nulliparae 
male and for cervical mucus 
factor versus no male and 
cervical mucus factor 
early follicular phase c 
versus other cycle phases 
endometriosis versus 
no endometriosis 
-0.10 
-0.26 
0.17 
0.32 
0.18 
0.13 
0.14 
0.13 
0.601 
0.053 
0.229 
0.017 
0.13 0.40 0.740 
-0.53 0.2B 0.063 
1.20 0.31 <0.001 
0.14 0.28 0.613 
A
 EECC = endometrial epithelial cell colonies. 
3
 The В value with which member of the pair a possible significant correlation is associated. A 
positive value indicates a positive correlation with the first variable of the pair; a negative value 
indicates a correlation with the second variable. 
0
 early follicular phase = cycle day 1 to 7. 
estimated between 10 and 50 cells. A highly significant difference in number of 
epithelial cell colonies was found between the early follicular phase (more cell 
colonies) versus the other cycle phases (Kruskal-Wallis test, P<0.001
>
 Figure 5.1). 
There was no significant difference between nulliparous and multiparous women. 
Although the number of endometrial epithelial cell colonies showed a slight 
correlation with the amount of flush medium recovered (Spearman correlation, 
r=0.230, P=0.0451 Figure 5.1), no significant difference was found between 
women with endometriosis versus women without endometriosis (Table 5.1). 
When grouped on the basis of a male and/or cervical mucus infertility factor, the 
number of endometrial epithelial cell colonies appeared to be significantly higher 
in women without these infertility factors (Wilcoxon test, P=0.030). Multiple 
regression analysis was used to determine simultaneously the contribution by 
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each of the four variables studied upon the number of developing endometrial 
epithelial cell colonies (Table 5.2). The early follicular phase was correlated with a 
significantly higher number of developing endometrial epithelial cell colonies 
(P<0.001). With the other variables no significant correlation was found, although 
the absence of a male and cervical mucus infertility factor nearly reached the 
level of significance (P=0.063). 
Effects of hormones and methylene blue on the growth potential of 
endometrial epithelial cells in vitro 
The addition of high concentrations of Ej and Ρ to the culture medium, 
comparable with levels in PF after ovulation, had no marked influence on the 
number of developing endometrial epithelial cell colonies (Wilcoxon's test, P=0.17, 
Figure 5.2) or the average size of these colonies. Short incubation of the cell 
suspension of uterine-tubal flush media with 0.01% methylene blue in 0.9% NaCI 
reduced the number of developing endometrial epithelial cell colonies significantly 
(Wilcoxon's test, P=0.002, Figure 5.2). However, those epithelial cell colonies that 
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Figure 5.2. Paired measurements of number of developing endometrial epithelial cell colonies 
(EECC) after dividing the flush medium samples into two equal parts: 
(A) one cell pellet (2) shortly incubated with 0.01% methylene blue 
(B) the culture medium of one cell pellet (2) supplemented with 590 nmol/L 
progesterone and 5800 pmol/L oestradiol-17ß . 
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did develop after incubation with 0.01% methylene blue solution had the same 
average size compared with the control culture. 
Discussion 
Although the exact mechanism of development of endometriosis remains to be 
solved, retrograde menstruation is accepted as a significant factor in its 
pathogenesis [18-20]. Several reports have focused on an iatrogenic contribution 
to retrograde seeding with tubal patency testing as part of infertility investigation 
[5-9,21]. Teilum and Madsen [21], who described seven cases of endometriosis 
after hystero-salpinogography, used their morphological findings to support the 
mesothelial metaplasia theory. With regard to the endometrial implantation theory, 
later studies have mentioned the presence of endometrial tissue in numerous PF 
samples after uterine-tubal irrigation [5-9]. The amount of refluxed endometrial 
cells was not quantified in any of these studies. In the present study, the amount 
of endometrial epithelial cells with adhering and proliferating properties was 
estimated by culturing the cell pellet of the flush medium recovered from the 
peritoneal cavity and counting the number of developing endometrial epithelial cell 
colonies. Each cell colony represents one or a small cluster of epithelial cells 
present in the flush medium. Endometrial epithelial cells could be identified in 
nearly all (92%) PF samples. A large interindividual difference in number of 
developing endometrial epithelial cell colonies was found. Especially in cultures 
from flush media obtained during the early follicular phase of the menstrual cycle 
a large number of epithelial cell colonies developed. This once more shows that 
endometrial cells in menstrual debris remains viable. With regard to the flush 
media obtained during the other phases of the menstrual cycle, the amount of 
endometrial epithelial cells with adhering and proliferating properties was 
comparable with the amount of such cells in PF, as a result of retrograde 
menstruation [12]. 
Factors which may influence the growth potential of these refluxed endometrial 
cells are the peritoneal hormonal environment and the use of methylene blue. 
Very high Ег and Ρ concentrations are reported in PF immediately after ovulation 
[14,15]. Based on the observation of a higher incidence of "luteinized unruptured 
follicle" in women with endometriosis, it has been suggested that these high E2 
and Ρ concentrations in PF have a negative influence on refluxed endometrial 
cells [22,23]. Our results do not support this theory because at least in vitro the 
presence of high E2 and Ρ levels do not prevent the development of numerous 
endometrial epithelial cell colonies. 
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Short incubation of the cell pellet with 0.01% methylene blue solution 
diminishes the number of developing endometrial epithelial cell colonies. With 
regard to possible adverse effects on sperm transport and embryo development, 
Coddington ef al. [24] have proposed, when a methylene blue solution is used 
for Pertubation, to flush the uterus and oviducts with lactated Ringer's solution 
after verification of tubal patency until the fluid leaving the tubes runs clear. 
Furthermore, they advised to aspirate the residual fluid from the cul-de-sac at 
termination of the procedure. The present study shows that a significant amount 
of endometrial cells can enter the peritoneal cavity after uterine-tubal flushing. So 
far a possible contribution of Pertubation to the development of endometriosis 
has not been excluded. Therefore aspiration of the residual Ringer's solution after 
tubal patency testing seems to be important when no methylene blue is added to 
the flush medium. 
By cytological and cell block analyses of PF, Bartosik ef a/. [6] reported a 
significantly higher incidence of endometrial tissue in PF after uterine-tubal 
flushing in women with endometriosis (76%) versus women without endometriosis 
(42%). They suggested a deficient uterotubal control mechanism in women 
destined to acquire endometriosis. Previously, Ayers and Friedenstab [25] had 
observed a relative hypotonia of the uterotubal junction in women with 
endometriosis. The present study adds new evidence to this theory because in 
women with endometriosis a significantly larger amount of flush medium was 
collected from the peritoneal cavity after flushing with a standard amount of flush 
medium. Although the number of developing epithelial cell colonies in culture 
correlated with the amount of flush medium recovered and was thus higher in 
women with endometriosis versus women without endometriosis, multiple 
regression analysis gave no significant difference. The fact that we, in contrast to 
Bartosik ef al. [6], did not find a significant difference between women with and 
without endometriosis may be explained in our usage of a rather large amount of 
flush medium (40 mL). Bartosik ef al. [6] did not mention the amount of flush 
medium used. In addition, both methods (cytologic analysis of the cell pellet and 
culture of the cell pellet) focus on different cell populations. Whereas with 
cytologic analysis mainly large intact glandular structures are observed [6], the 
developing epithelial cell colonies in culture derive from single cells and small 
clusters of cells. 
A uterotubal hypotonia can also result in an increased amount of refluxed 
endometrial cells during menstruation and therefore forms an additional factor in 
the development of endometriosis. In a previous study however, in which we 
cultured the cell pellet of PF obtained during the early follicular phase before 
Pertubation, no difference in number of endometrial epithelial cell colonies 
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between infertile women with and without endometriosis was found [12]. This may 
be explained by the fact that the number of developing endometrial epithelial cell 
colonies from one PF sample does not necessarily correlate with the total amount 
of refluxed cells, especially because retrograde menstruation is a continuous 
process during several days. Furthermore, the group of infertile women without 
endometriosis in our previous study contained a relatively large number of 
women with unexplained infertility. These women have also been associated with 
an increased amount of retrograde menstruation to explain infertility-related 
changes in the peritoneal environment [10,11]. In fact, in our previous study, the 
number of epithelial cell colonies was significantly higher in women without male-, 
cervical mucus-, mechanical-, and menstrual cycle-related infertility factors [12]. 
We therefore introduced a male and/or cervical mucus infertility factor in the 
present study as a variable (all women studied had a regular ovulatory cycle and 
no mechanical infertility factor). The absence of a male and cervical mucus 
infertility factor correlated with both the amount of flush medium recovered and 
the number of epithelial cell colonies and nearly reached the level of significance 
(P=0.053 and 0.063 respectively). 
As a conclusion, uterine-tubal flushing results in varying numbers of 
endometrial epithelial cells in PF capable of adherence and proliferation in vitro. 
This number is reduced by adding methylene blue to the flush medium. 
Furthermore, evidence is provided for a relative hypotonia of the uterotubal 
junction in infertile women with endometriosis and infertile women without male-, 
cervical-, mechanical-, and menstrual cycle-related infertility factors. A uterotubal 
hypotonia may be a factor in the etiology of both endometriosis and infertility, as 
a result of an increased amount of retrograde menstruation. 
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Chapter 6 
Quantification of CA 125 in peritoneal fluid: inhibition of the 
CA 125 respons in the one-step immunoradiometric assay 
and establishment of a two-step assay format 
R.F.P.M. Kruitwagen, R.J. van den Berg, M.F.G. Sogers, L.G. Poets, 
W.N.P. Willemsen, R. Rolland, C.M.G. Thomas 
(Clinical Chemistry 37:760-761, 1991) 
105 
We have tested the accuracy of the one-step assay format (i.e., 100 μ!, of 
sample incubated for 20 hours (h) at room temperature (RT) along with capture-
and signal-monoclonal antibody (MAb)) versus the two-step procedure (i.e., 100 
μ|_ of sample incubated first for 20 h at RT with capture-MAb, then with signal-
MAb for 3 h at RT) for quantifying CA 125 in peritoneal fluid (PF) by 
immunoradiometric assay (IRMA). 
Klug ef al. [1] reported that the most practical procedure for assaying CA 125 
in serum samples is the one-step IRMA, although our experiments with either 
assay format demonstrate excellent parallelism between serially diluted serum 
samples over a wide range of sample volumes (0.1 - 3.12 μΐ) and the respective 
standard dose-response curves (range: 7.6 - 500 arb. units/mL) as shown in 
Figure 6.1. Sample concentrations are calculated by correcting the concentrations 
of the unknowns as read off the standard curve according to the dilution factor 
(i.e., 100 μΐ/μί. of unknown). 
Several groups [2,3] applied the one-step assay format to measure CA 125 in 
PF from women with various stages of endometriosis. They reported PF 
concentrations ranging between 11 and 375 arb. units/mL, but these results 
appear to be inaccurate because the PF dilution curves did not run parallel the 
standard dose-response curves [2]. Using either assay format, we observed that 
serially diluted PF samples (three from cases of endometriosis, two from women 
with a normal-looking pelvis) show a high-dose "hook" effect in the one-step IRMA 
(Figure 6.1, upper panel), but excellent parallelism in the two step format (Figure 
6.1, lower panel). 
To explain the different behavior of PF in the one-step IRMA, we speculate that 
the structure of the CA 125 molecule in PF differs from that in serum. This analyte 
in PF may demonstrate a much lower affinity for the capture MAb (solid phase-
liquid interaction) than for the same signal MAb (liquid-liquid interaction). The 
concentrations obtained from the dilution series of the five PF samples (two-step 
format) compared with the results of the 50 μL· PF samples (one-step format: 
these results in paracentheses) are 1800 (440); 2400 (140); 4800 (200); 5600 
(380); and 5700 (130) arb. units/mL, respectively. 
In conclusion, (a) the previously reported concentrations CA 125 in PF 
determined with the one-step IRMA are not accurate; (b) the limited parallelism of 
non-serum unknowns with the one-step format IRMA can be checked by 
assaying at least two different sample volumes to ensure parallelism; (c) to avoid 
nonparallelism in these cases, kit manufacturers should include a two-step assay 
procedure with their kit-information; (d) the much higher CA 125 concentrations in 
PF presented here may have implications for current pathophysiological theories 
regarding increased CA 125 in serum and PF of women with endometriosis. 
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Chapter 7 
High CA 125 concentrations in peritoneal fluid of normal 
cyclic women with various infertility-related factors as 
demonstrated with two-step immuno-radiometric assay 
R.F.P.M. Kruitwagen, C.M.G. Thomas, LG. Poels, AM. Koster, W.N.P. Willemsen, 
R. Rolland 
(Fertility and Sterility, in press) 
Abstract 
Objective: To determine CA 125 concentrations and total amounts in peritoneal 
fluid (PF) of women with various infertility-related factors throughout the menstrual 
cycle. 
Design: Peritoneal fluid was obtained at laparoscopy. CA 125 was determined 
using the assessed two-step immunoradiometric assay (IRMA) which, in contrast 
to the one-step IRMA, give valid results. 
Setting: University Hospital Nijmegen (The Netherlands). 
Patients: One-hundred-six infertile women with a regular and ovulatory cycle were 
included. 
Interventions: None. 
Main outcome measure(s): The mean PF CA 125 concentration and total 
amount were significantly lower during the luteal phase as compared to other 
phases of the menstrual cycle. No correlation was found with the presence or 
absence of endometriosis, adhesions, a male - and/or cervical mucus infertility 
factor, and with patent or closed fallopian tubes. 
Results: Peritoneal fluid CA 125 concentrations varied from 630 to 12000 arb. 
U/mL (mean ± SD = 3437 ± 2286). Total PF CA 125 amounts (concentration χ 
PF volume) varied from 1760 to 133000 arb U (mean ± SD = 30219 ± 26841). 
Conclusions: CA 125 secretion into the abdominal cavity varies during the 
menstrual cycle. Retrograde menstruation is not the main source of CA 125 in 
PF. 
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Introduction 
In 19Θ1 Bast ef al. [1] developed the monoclonal antibody (MAb) OC 125 by 
immunization with the use of an epithelial ovarian carcinoma cell line. The 
antigenic determinant defined by this MAb, was designated CA 125 which has 
been demonstrated to be associated with the coelomic epithelium and all its 
normal and neoplastic derivatives with exception of the normal mesothelial lining 
of the ovary [2,3]. Endometriotic tissue also expresses the CA 125 antigen [4]. 
Since multiple CA 125 epitopes were associated with each antigen molecule, an 
immunoradiometric assay (IRMA) could be developed to quantify CA 125 in 
serum [5,6]. Klug ef al. [6] compared the one-step and two-step format IRMA for 
serum samples. The simultaneous (one-step) format IRMA appeared to be 
superior, since it provided highest sensitivity at CA 125 concentrations below 
1000 arb. units/mL Theoretically, very high CA 125 levels could lead to falsely 
decreased values with the one-step assay due to the high-dose hook effect. 
However, within the standard working range (6.5 - 500 arb. units/mL), only 
concentrations higher than 40000 arb. units/mL would result in an apparent 
anomalous unit value below 500 arb. units/mL [6]. 
Initially, studies focused on the use of CA 125 as a serum tumor marker of 
malignant ovarian disease [7]. In women with endometriosis, mild elevations of 
the serum CA 125 concentration were also observed, and its use as serum 
marker for endometriosis was investigated [4,8-10]. The predictive value appeared 
to be low, especially in women with minimal and mild endometriosis. In order to 
evaluate whether CA 125 concentrations in peritoneal fluid (PF) would be a more 
predictive marker for endometriosis than serum concentrations, CA 125 in PF was 
measured with the one-step format IRMA as described for serum samples [11-
13]. No significant difference in mean PF CA 125 concentrations were found 
between women with and without endometriosis. However, when PF samples 
were diluted to validate the assay, no parallelism was found with the standard, so 
that the results can be considered invalid [12,13]. Recently we reported that serial 
dilutions of PF samples measured in the one-step format IRMA showed a 
decreased response within the working range as defined for serum samples, i.e. 
up to 500 arb. units/mL [14]. The decreased response was not observed in the 
two-step format IRMA with much higher PF CA 125 concentrations as a result 
(1800-5700 arb. units/mL). 
In the present study we measured the CA 125 concentrations and total 
amounts in PF, as determined with the assessed two-step format IRMA, 
throughout the menstrual cycle in normal cyclic women with several infertility 
related factors (endometriosis, occluded tubes, adhesions, male and/or cervical 
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mucus infertility factor). 
Material and Methods 
Patients 
A total of 106 women for whom a diagnostic laparoscopy was planned as part 
of their infertility investigation participated in the study. All women had regular and 
ovulatory cycles based on basal body temperature (BBT) curves and serum 
progesterone (P) levels compatible with postovulatory states. All women gave 
informed consent. 
Laparoscopy was planned during various phases of the menstrual cycle based 
on previous cycle lengths and BBT curves. At laparoscopy, a blood sample was 
taken for Ρ measurement, which was used retrospectively for a more precise 
cycle phase definition (early follicular phase: cycle day 1 to 7; midfollicular phase: 
cycle day >7 and serum Ρ <2 nmol/L; periovulatory phase: cycle day >12 and 
serum Ρ >2 and <10 nmol/L; luteal phase: cycle day >12 and serum Ρ г 10 
nmol/L). 
The following variables were recorded for each woman: (1) the presence or 
absence of a male and/or cervical mucus infertility factor, (2) the cycle phase 
(early follicular, midfollicular, periovulatory, or luteal phase), (3) the presence or 
absence of endometriosis, (4) the presence or absence of adhesions, and (5) 
closed or patent fallopian tubes. 
Reports have suggested that in women with unexplained infertility a higher 
amount of retrograde menstruation may be responsible for alterations in the 
peritoneal environment [15]. Menstrual fluid contains high concentrations of CA 
125 [16]. Therefore, a male and/or cervical mucus infertility factor was also 
introduced as a variable. A normal semen analysis was defined as a sperm count 
of >20x106/mL with >60% good motility and >60% normal morphology. A normal 
postcoital test was defined as >5 propulsive spermatozoa per high power field. 
Laparoscopy was performed using the double-puncture technique. PF present 
in the pouch of Douglas was aspirated at the beginning of the laparoscopic 
examination. The total volume of the PF was measured, kept at 40C and 
centrifuged within 30 minutes at 200 χ g for 10 minutes. The supernatant was 
stored at -200C until assayed. When endometriosis was identified, it was staged 
according to the revised American Fertility Society classification [17]. 
Serum progesterone 
Determination of Ρ levels in serum were performed with a specific charcoal 
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radioimmuno assay described by Thomas ef a/. [18]. This assay included 
extraction with diethylether. The intra- and interassay coefficients of variation for 
means of duplicate determinations were 4.1% and 9.1% after 36 consecutive 
assay runs and a mean of the serum pool of 39 nmol/L. 
Serum and PF CA 125 
CA 125 concentrations in serum of 74 women were determined with the 
simultaneous (one-step) format IRMA as described by Klug eí al. [6]. Reagents, 
buffers, and standards from the Centocor CA 125 RIA kit (Centocor, Inc., 
Malvern, PA, USA) were used. TTie minimal detectable concentration is 1.4 arb. 
units/mL. As an indicator of assay precision, the intra- and interassay coefficients 
of variation for means of duplicate determinations were calculated from 3 serum 
pools (mean concentrations: 35, 56, and 189 arb. units/mL). After 10 assay runs 
these were 1.8% and 8.8%, 2.5% and 6.2%, and 3.1% and 6.3% respectively. 
CA 125 concentrations in PF were determined with a two-step IRMA as 
reported previously [6,14]. Briefly, PF and capture-MAb were incubated for 20 
hours at room temperature, washed, and incubated with signal-MAb for 3 hours 
at room temperature. The intra- and interassay coefficients of variation for means 
of duplicate determinations were calculated from 2 PF pools (mean 
concentrations: 53 and 120 arb. U/mL). After 9 and 12 assay runs these were 
4.4% and 11%, and 4.4% and 10% respectively. 
CA 125 total amount in PF was calculated by multiplying CA 125 concentration 
with PF volume. 
Statistics 
The distribution of the data was normalized by log-transformation before 
statistics were applied. Standard statistical methods (f-test, analysis of variance 
followed by Tukey contrast) were applied to investigate univariate the relations 
between the variables studied (cycle phase, endometriosis, tubal patency, 
adhesions, male and/or cervical mucus infertility factor) and PF volume, CA 125 
concentration in serum, CA 125 concentration and total amount in PF. In order to 
determine simultaneously the contribution by each of the variables studied upon 
PF CA 125 concentration and total amount, multiple regression analysis was 
used. 
Results 
Table 7.1 shows the distribution of the five variables studied, and the 
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Table 7.1. Distribution of the variables studied with regard to PF volume, serum CA 125 
concentration, PF CA 125 concentration and total amount. 
variable 
no male and 
cervical mucus factor 
male and/or 
cervical mucus factor 
cycle phase: 
early follicular 
midfollicular 
periovulatory 
luteal 
endometriosis: 
not present 
stage 1 
stage ll/lll 
patent iutoes 
closed tubes 
adhesions 
no adhesions 
serum 
N* 
31 
43 
20 
20 
16 
IB 
39 
29 
6 
66 
в 
12 
62 
CA 125 
concentration 
mean ± SD 
arb. 
11.7 
14.9 
14.0 
14.0 
12.1 
13.8 
13.1 
13.2 
18.0 
13.9 
10.9 
14.8 
13.3 
U/rnL 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
5.9 
9.6 
9.4 
9.1 
7.0 
7.9 
7.5 
8.7 
11.8 
8.7 
4.8 
11.6 
7.7 
PF volume 
mean ± SO 
mL 
9.0 ± 6.2 
9.9 ± 7.4 
7.3 ± 4.6 
6.7 ± 4.5 
13.4 ± 8.9 
10.2 ± 6.4 
9.1 ± 7.4 
9.0 ± 5.5 
Í5.6 ± 9.4 
9.6 ± 6.9 
9.0 ± 7.1 
8.4 ± 4.8 
9.7 ± 7.2 
NA 
47 
59 
23 
28 
29 
26 
51 
48 
7 
93 
13 
17 
89 
PF CA 125 
concentration 
mean I ± : SD 
arb. U/mL 
3080 
3720 
4310 
3910 
3370 
2220 
3070 
3780 
3770 
3610 
2200 
3370 
3450 
± 
± 
± 
± 
+ 
± 
± 
+ 
± 
+ 
+ 
± 
+ 
1870 
2550 
2990 
2130 
2070 
1360 
2170 
2400 
2220 
2340 
1350 
2210 
2310 
total amount 
mean ± SD 
arb. U 
26900 ± 21500 
32900 ± 30300 
29100 ± 23200 
24400 ± 79200 
45600 ± 37000 
20500 ± 75ÍOO 
27500 ± 26700 
29900 ± 23700 
5Í600 ± 27200 
37800 ± 27700 
79700 ± 76300 
23600 ± 78200 
37400 ± 28700 
* N = number of women 
corresponding results with regard to PF volume, serum CA 125 concentration, PF 
CA 125 concentration and total amount. Endometriosis was diagnosed in 55 
women (48 stage I, 4 stage II, and 3 stage III). 
Peritoneal fluid volume 
Peritoneal fluid volume of 106 samples varied from 1.0 to 38.0 mL (mean ± 
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SD = 9.5 ± 6.Θ mL). No significant differences in mean PF volume existed 
between women without, with stage I, or stage ll/lll endometriosis, between 
women with open and closed fallopian tubes, between women with and without 
adhesions, and between women with and without a male and/or cervical mucus 
infertility factor. A significant difference in mean PF volume existed between the 
various phases of the menstrual cycle (analysis of variance, P=0.002), the mean 
PF volume during the periovulatory phase being significantly higher compared to 
the early- and midfollicular phase (Tukey P<0.05). No significant difference with 
the luteal phase was obtained. 
Multiple regression analysis was used to determine simultaneously the 
influence of each of the five variables studied. Only the phase of the menstrual 
cycle during which the PF was obtained had a significant association with the PF 
volume (higher PF volume during the periovulatory phase versus the early- and 
midfollicular phase, P=0.004 and 0.001, respectively). 
Serum CA 125 concentrations 
The serum CA 125 concentration varied from 4.6 - 39 arb. units/mL (mean 
13.5 ± 8.4 arb. U/mL). Three women had a CA 125 concentration > 35 arb. 
U/mL There were no significant differences in mean serum CA 125 concentration 
between women without, with stage I, or stage ll/lll endometriosis, between 
women with open and closed fallopian tubes, between women with and without 
adhesions, between women with and without a male and/or cervical mucus 
infertility factor, and between the different phases of the menstrual cycle. 
When investigating simultaneously the influence of the five variables studied, 
no significant association with one of the five variables was found as established 
while using multiple regression analysis. 
Peritoneal fluid CA 125 concentrations 
The PF CA 125 concentration varied from 630 - 12000 arb. units/mL (mean 
3430 ± 2290 arb. U/mL). The mean PF CA 125 concentration appeared to 
decrease during the menstrual cycle (Figure 7.1). The differences between the 
various phases of the menstrual cycle were significant (analysis of variance, 
P=0.004), the mean PF CA 125 concentration being significantly increased during 
the early- and midfollicular phase compared to the luteal phase (Tukey, P<0.05). 
Furthermore, the mean PF CA 125 concentration was significantly higher in 
women with patent versus closed fallopian tubes (t-test, P=0.011). No significant 
differences were observed between women with versus without adhesions, 
between women without, with stage I, or stage ll/lll endometriosis, and between 
women with and without a male and/or cervical mucus infertility factor. 
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Figure 7.1. 
CA 125 concentrations in PF 
related to different phases of 
the menstrual cycle. Horizontal 
line = mean concentration. 
Multiple regression analysis gave similar results, the luteal phase being 
associated with significantly lower PF CA 125 concentrations (Table 7.2). Also 
closed fallopian tubes were associated with lower PF CA 125 concentrations, the 
difference tending to significance (P=0.054). 
Peritoneal fluid CA 125 total amount 
The total amount of PF CA 125 varied from 1760 to 133000 arb. units (mean 
30200 ± 26800 arb. units). The mean PF CA 125 quantities were significantly 
different during the various phases of the menstrual cycle (analysis of variance, 
P=0.026), the mean PF CA 125 total amount being significantly lower during the 
luteal phase than during the periovulatory phase (Tukey, P<0.05). Although the 
mean PF CA 125 total amount was highest during the periovulatory phase, no 
significant differences were obtained when compared with the early- and 
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Table 7.2. Multiple regression analysis for PF CA 125 concentrations and total amounts 
among infertile women. 
paired variables 
PF CA 125 concentration 
В value * SE 
PF CA 125 total amount 
В value* SE 
male and/or cervical mucus 
factor versus no male and 
cervical mucus factor 
-0.03 0.12 0.780 -0.04 0.19 0.826 
luteal phase versus 
early follicular phase 
midfollicular phase 
periovulatory phase 
endometriosis versus 
no endometriosis 
patent tubes versus 
closed tubes 
adhesions versus 
no adhesions 
-0.54 
-0.57 
-0.41 
0.19 
0.37 
-0.04 
0.18 
0.17 
0.16 
0.12 
0.19 
0.16 
0.003 
« λ 007 
0.014 
0.119 
0.054 
0.816 
-0.29 
-0.25 
-0.77 
0.23 
0.46 
-0.11 
0.27 
0.25 
0.25 
0.19 
0.29 
0.25 
0.272 
0.310 
0.003 
0.227 
0.116 
0.652 
A
 The В value with which member of the pair a possible significant correlation is associated. A 
positive value indicates a positive correlation with the first variable of the pair (e.g., patent 
versus closed tubes); a negative value indicates a reciprocal correlation with the first variable 
(e.g., luteal phase versus other cycle phases). 
midfollicular phase. No significant differences were observed between women 
without, with stage I, or stage ll/lll endometriosis, between women with versus 
without adhesions, between women with and without a male and/or cervical 
mucus infertility factor, and between women with patent versus closed fallopian 
tubes, although the latter comparison tended to significance (lower CA 125 
content in women with closed tubes, P=0.053). 
Multiple regression analysis gave equal results. Only the luteal phase was 
associated with a significantly lower total amount of PF CA 125 as compared to 
the periovulatory phase (Table 7.2). 
116 
Discussion 
Initial papers on CA 125 concentrations in PF of women with endometriosis 
have reported concentrations varying from 11 to 375 arb. units/mL [11,12,19,20], 
using the simultaneous (one-step) format IRMA, especially developed and 
validated for serum samples [6]. However, in contrast to serum samples, PF CA 
125 concentrations did not show parallelism between serially diluted samples and 
the standard dose-response curve so that the results were considered invalid 
[12]. Moretuzzo et al. [13] measured CA 125 concentrations in peritoneal lavage 
fluid (150 mL, i.e. diluting the PF samples approximately 10-15 fold), which should 
result in lower CA 125 concentrations than those reported in PF. Instead, CA 125 
concentrations up to 500 arb. units/mL were found. Furthermore the peritoneal 
lavage fluid samples did not show parallelism at dilutions less than 1:5. In a 
previous paper we reported that the PF CA 125 concentrations in earlier reports 
were anomalously low based on a decreased response using the one-step format 
IRMA [14]. In the two-step format IRMA no lowered response could be noted, 
thus resulting in much higher PF CA 125 concentrations. The cause of this 
interference with the one-step assay remains speculative. It could be due to 
different molecular forms with regard to repeating or hidden epitopes for CA 125 
in PF versus serum, or could be explained by a cross reactivity due to shared 
epitopes in unrelated molecules present in PF. Furthermore, substances present 
in PF could be able to interfere with the affinity of CA 125 epitopes with either the 
capture MAb (solid phase - liquid interaction) or the same signal MAb (liquid -
liquid interaction). 
The present study confirms our previous data on PF CA 125 concentrations 
using the two-step format IRMA with values varying from 630 - 12000 arb. 
units/mL Peritoneal fluid CA 125 concentrations diminished significantly during the 
menstrual cycle and were also lower in women with closed fallopian tubes, which 
condition prohibites the occurrence of retrograde menstruation. These data could 
suggest a role for retrograde menstruation, especially since very high CA 125 
concentrations (above 100000 arb. units/mL) have been found in menstrual fluid 
[16]. However, PF CA 125 concentrations can also be influenced by a varying PF 
volume during the menstrual cycle as a consequence of ovarian activity [21], 
which was also found in the present study. The mean PF volume increased 
during the follicular phase of the menstrual cycle, reaching the highest levels 
during the periovulatory phase and declined again during the luteal phase. 
Therefore, the total PF CA 125 amount could be more indicative whether or not 
retrograde menstruation is the main source of the CA 125 amount in PF. We did 
not find a significant difference in PF CA 125 total amount between women with 
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patent and closed fallopian tubes. Furthermore, the PF CA 125 total amount was 
highest during the periovulatory phase, although no significant difference was 
found with the early- and midfollicular phase. These data points towards another 
source of CA 125 secretion into the abdominal cavity besides retrograde 
menstruation, which may include the peritoneum. Van Niekerk ef el. [22] has 
shown that a low but significant amount of CA 125 epitopes are shed in culture 
supernatants of mesothelial cells. The cyclic variation of this CA 125 secretion is 
in agreement with Jäger ef al. [23], who evaluated serum CA 125 concentrations 
in women throughout the menstrual cycle, and found increased serum 
concentrations parallel to follicular growth. They also observed extremely high 
serum CA 125 concentrations in women with ovarian hyperstimulation [24]. 
Serum CA 125 concentrations observed in the present study are in good 
agreement to those reported in the literature [4,8-13,16,19]. Barbieri ef al. [4,8] 
suggested that elevated serum CA 125 concentrations in women with 
endometriosis were directly caused by endometriotic lesions shedding cell-
surface antigens into the systemic circulation. Inflammation associated with 
endometriosis was suggested as an additional factor causing an increase in the 
rate at which CA 125 is shed from the membranes of endometriotic lesions [8]. 
One would expect this also be reflected in PF CA 125 concentrations and total 
amounts. Although a positive correlation was found between the presence of 
endometriosis and both PF CA 125 concentrations and total amounts, no 
statistical significance was reached. However, it has to be noted that only a 
limited number of women with stage II and III endometriosis were included. 
Therefore, the statistical power is very low for finding an association between 
advanced stages of endometriosis and PF CA 125 concentrations and total 
amounts. Because high PF CA 125 concentrations were also found in women 
without endometriosis, we suggest an additional factor to explain elevated serum 
CA 125 concentrations in women with more advanced stages of endometriosis. 
The peritoneum normally functions as a barrier, so that only a limited diffusion of 
CA 125 antigen occurs from the peritoneal cavity into the circulation [25]. In those 
women with more advanced stages of endometriosis, the peritoneum is impaired 
at the sites of endometriotic implants, resulting in a higher release of CA 125 
antigen into the circulation and elevated serum CA 125 concentrations. 
As a conclusion, we determined the PF CA 125 concentrations and total 
amount, using the two-step format IRMA. PF CA 125 concentrations (and total 
amount) in both women with and without endometriosis were much higher than 
the previously reported PF CA 125 concentrations as based on insufficiently 
validated immunoassays of the one-step format. Although the main source of CA 
125 epitopes in PF remains unknown, especially retrograde shedding of CA 125 
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epitopes during menstruation appears to be of less importance. An additional 
factor to explain higher serum CA 125 levels in women with more advanced 
stages of endometriosis may be the impaired peritoneum, resulting in a higher 
release of CA 125 antigen from the peritoneal cavity into the circulation. 
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Chapter 8 
General discussion 
Despite intensive research, endometriosis remains an entity with many 
unresolved questions regarding to its histo- and pathogenesis and its association 
with infertility. So far, definite diagnosis can only be made after laparoscopy and 
histologic examination of biopsies taken at laparoscopy. Classification systems 
based on laparoscopic findings have been demonstrated to be inaccurate. 
Attempts have been made to develop a non-invasive test for the presence of 
endometriosis. Such a test may also be usefull in monitoring the progression of 
the disease, and in devising a more precise classification system. In the previous 
chapters, several of these aspects were investigated. 
At present, the endometrial implantation theory is widely accepted among 
gynecologists. Although endometrial cells capable of adherence and proliferation 
have been identified in antegrade menstrual fluid [1], no studies were carried out 
to evaluate the presence of such cells (i.e. epithelial and stromal cell types) in 
peritoneal fluid (PF). Several studies have identified viable endometrial glandular 
structures in PF even during the luteal phase of the menstrual cycle. None of the 
authors appeared to be surprised that these tissue fragments, if not eliminated by 
the immune system, had not already adhered to the peritoneum as an initial step 
of implantation. The study of Willemsen et al. [2] suggests that these tissue 
fragments are not capable of adherence as the cultures of PF obtained during 
the late follicular phase did not reveal proliferating endometrial cells in any of 115 
PF samples examined. Therefore, we investigated PF obtained during the early 
follicular phase (cycle day 1 to 7) using the same culture technique. In the 
majority of women studied, both with and without macroscopic endometriosis, 
adhering and proliferating endometrial epithelial cells could be identified in culture. 
Presumably, these cells in vivo adhere to the peritoneum and/or are eliminated by 
the immune system during the follicular phase. 
Most arguments put forward thus far supporting the endometrial implantation 
theory do not exclude, or are in conflict with the theory of coelomic metaplasia 
through induction. Monoclonal antibodies (MAbs) have been used to distinguish 
and characterize epithelial tissues of different origin [3,4]. We investigated if the 
immunocytochemical marker profile of endometriotic epithelial, endometrial 
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epithelial and normal mesotheiial cells could discriminate between these cell 
types, and clarify the origin of endometriotic cells. Endometriotic and endometrial 
epithelial cells had a similar ¡mmunocytochemical profile. These cells could be 
distinguished from normal mesotheiial cells with the epithelial markers HMFG-2 
and BW 495/36, and also with the newly developed MAb NEND-3. So far, NEND-
3 appears to be specific for active endometrial and endometriotic epithelial cells. 
Although these data are consistent with the endometrial implantation theory, they 
again do not exclude the metaplasia theory. If mesothelium undergoes 
metaplastic transformation to endometrial-like tissue, endometrial-like antigens may 
be expressed also. In this respect, an altered antigen expression of mesotheiial 
cells has been described with regard to the development of ovarian carcinoma 
[5-7]. 
During the last decade, two factors (luteinized unruptured follicle (LUF) 
syndrome and alterations in the immune system) which may predispose the 
development of endometriosis have been investigated. 
Whereas it has been proposed that the immune system is operative in limiting 
ectopic growth of endometrial cells by eliminating these cells [8], others have 
indicated that the activated immune system may promote ectopic growth of 
endometrial cells by producing growth factors [9]. In this thesis, alterations in the 
immune system have not been examined. 
Considerable controversy exists with regard to the association between LUF 
and endometriosis. The main cause of this controversy appears to be difficulties 
in diagnosing LUF. Three methods have been used: (1) laparoscopy with 
identification of an ovulation stigma, (2) steroid hormone measurements in PF, 
and (3) ultrasound. Identification of an ovulation stigma at laparoscopy is 
unreliable. Recently, Scheenjes et al. [10] using ultrasound demonstrated that 
already 1.5 days after ovulation no conclusions can be drawn on the presence or 
absence of an ovulation stigma. The value of changes in steroid hormone levels 
in PF for the retrospective diagnosis of ovulation or the occurrence of LUF has 
also been debated. 
We measured both pre- and postovulatory oestradiol-17/? (Ej) and 
progesterone (P) concentrations in PF, using ultrasound for ovulation detection. 
Oestradiol-17^ concentrations before and after ovulation showed a wide 
distribution of individual values with a marked overlap between both groups. More 
consistent changes were found in PF Ρ concentrations, although a small overlap 
between pre- and postovulatory values remained. This overlap was due to the 
fact that in some women a cystic corpus haemorrhagicum had developed shortly 
after ovulation. These results indeed confirm that the incidence of LUF wil be 
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overestimated when the diagnosis is only based on steroid hormone 
concentrations in PF. Despite the fact that with ultrasonic ovulation detection the 
formation of a cystic corpus luteum can also be misinterpreted as being a LUF, 
ultrasound appears to be the method of choice for identifying LUF. The more so 
as LUF cycles show a characteristic follicular growth pattern in which, following 
the LH peak, a rapid increase in follicle diameter occurs, exceding 30 mm. 
The theory of Koninckx et al. [11] that high E2 and Ρ concentrations, as 
normally seen in PF immediately after ovulation, prevent the development of 
endometriosis, does not find support in our culture experiments. After uterine-
tubal irrigation, refluxed endometrial epithelial cells showed similar growth 
characteristics in cultures with and without addition of high concentrations of 
these steroid hormones to the culture medium. 
Several studies made clear that retrograde menstruation is a significant factor 
in the development of endometriosis. Uterine outflow obstructions are known to 
predispose the development of endometriosis. Ayers and Friedenstab [12] 
confirmed the earlier observation of Sampson [13], that women with 
endometriosis had a relative hypotonia of the uterotubal junction. This may be an 
additive factor in the development of endometriosis leading to an increased 
amount of retrograde menstruation. Furthermore, retrograde menstruation has 
been proposed as a causal factor for infertility-related alterations in the peritoneal 
environment of women with unexplained infertility, including women with 
endometriosis [14]. Yet, no studies have tried to quantify the amount of 
retrograde menstruation. In our study we cultured PF obtained during the early 
follicular phase (cycle day 1 to 7) and observed a surprisingly large interindividual 
difference in number of developing endometrial epithelial cell colonies. Since each 
cell colony represents one or a small cluster of cells, the number of developing 
cell colonies in vitro very likely correlates with the number of endometrial epithelial 
cells capable of adherence and proliferation, present in PF. This number was 
significantly higher in women without a mechanical-, male-, and cervical mucus 
infertility factor, being consistent with the concept that an increased amount of 
retrograde menstruation occurs in women with unexplained infertility. No 
significant distinction in number of cell colonies was obtained between infertile 
women with endometriosis (mostly minimal) and infertile controls. It has to be 
noted that this culture technique bears several limitations as a method for 
quantifying the amount of retrograde menstruation. One PF sample does not 
necessarily correlates with the total amount of retrograde menstruation (including 
the number of viable endometrial epithelial cells), since retrograde menstruation is 
a continuous process during several days. Furthermore, both the refluxed viable 
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and the degenerating endometrial cells are of importance in the induction theory. 
A more precise method to estimate the amount of retrograde menstruation may 
be the measurement of the concentration of endometrial secretion products 
(preferably with a long half life) in PF at the end of the menstruation, although the 
presence of more extended endometriosis could be a confounding factor. 
We also cultured the cell pellet of PF after uterine-tubal irrigation in infertile 
women. The fact that a significantly greater amount of flush medium could be 
recovered from the peritoneal cavity of infertile women with endometriosis when 
compared to infertile controls provides further evidence in support of the theory 
of an uterotubal hypotonia in women with endometriosis. It remains speculative, 
however, if this hypotonia of the uterotubal junction is a primary event which 
through a greater amount of retrograde menstruation predisposes to 
endometriosis. It may also be secondary to the presence of endometriosis, for 
instance being induced by altered prostaglandin concentrations in PF. 
Flush media obtained after uterine-tubal flushing contained variable amounts of 
adhering and proliferating endometrial epithelial cells. Short incubation of the cell 
pellets from flush media with a methylene blue solution had a significant adverse 
effect on the growth potential of these cells. To eliminate the possibility of an 
iatrogenic contribution to endometriosis by uterine-tubal flushing, it is advisable to 
reduce the number of refluxed endometrial cells capable of adherence and 
proliferation. This can be achieved by aspirating the flush medium after tubal 
patency testing, or by adding methylene blue to the flush medium. 
Only an accurate diagnosis of endometriosis, its extent and degree of activity, 
allows valid comparison between groups of women. Several studies determined 
serum and PF CA 125 concentrations with the one-step format 
immunoradiometric assay (IRMA) to evaluate its use as a marker for the presence 
and degree of endometriosis. However, the antigenic determinant CA 125 has 
been demonstrated to be associated with the coelomic epithelium and all its 
normal and neoplastic derivatives with the exception of the normal mesothelial 
lining of the ovary. This indicates that the use of CA 125 determinations as 
marker for endometriosis is probably of limited value, except, as is the case with 
ovarian carcinomas, endometriotic lesions secrete large amounts of CA 125. 
Indeed, elevated serum CA 125 concentrations were found more consistently only 
in women with more advanced stages of endometriosis. Studies focusing on PF 
CA 125 concentrations also used the one-step format IRMA as developed for 
serum samples. The results were invalid since the PF dilution curves did not 
follow the standard dose response curve [15,16]. We demonstrated that using the 
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two-step format IRMA excellent parallelism in the assay is obtained, resulting in 
much higher PF CA 125 concentrations in infertile women with various infertility 
related factors than previously reported. No differences in PF CA 125 
concentrations were found between women with and without endometriosis, 
although it has to be noted that the majority of women in this study had only 
minimal endometriosis. Furthermore, retrograde menstruation containing 
endometrial CA 125 epitopes had no major influence on both PF CA 125 
concentration and total amount. The main source of the PF CA 125 epitopes 
remains unknown and may include the mesothelium itself. Since all women had 
high PF CA 125 compared to serum CA 125 concentrations, we propose an 
alternative theory to explain elevated serum CA 125 concentrations in women with 
more extended endometriosis. Peritoneal fluid contains high amounts of 
molecules with CA 125 epitopes and normally the peritoneum functions as a 
barrier for these molecules. This results in the reported high ratio of PF to serum 
CA 125 concentrations. In women with more extended endometriosis, the 
peritoneum barrier is impaired, resulting in a higher release of CA 125 epitopes 
into the circulation, thereby causing higher serum CA 125 concentrations. 
Specific secretion products of endometriotic cells have not been described so 
far. Determination of specific secretion products of both endometriotic and 
endometrial cells in serum and PF may be useful to estimate the activity of 
endometriosis. Since retrograde menstruation is a confounding factor especially 
with regard to PF, determination of secretion products during the luteal phase 
would be of interest. On the other hand, determination of these products at the 
end of menstruation could indicate the amount of retrograde menstruation. Two 
studies have investigated the value of the immunologically indistuiguishable 
endometrial proteins PEP and PP14 for diagnosing endometriosis [17,18]. The 
results were of interest. Differences in PF [17] and serum [18] concentrations 
were found between women with and without endometriosis. The total amount of 
these secretion products may be an even better indication with regard to the 
activity of endometriotic lesions. This topic, however, remains to be investigated. 
In conclusion, this thesis provides further evidence that besides immunologic 
alterations, retrograde menstruation may also be an important mediating factor in 
the pathogenesis of endometriosis and associated infertility. A major disturbing 
factor in studying the association between these three entities (retrograde 
menstruation, endometriosis, infertility) is the lack of an accurate classification 
system, which so far only includes number, size, and location of macroscopic 
endometriosis. Future studies should focus on specific endometriotic and 
endometrial secretion products in PF which may be useful in determining the 
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amount of retrograde menstruation as well as the activity of the endometriotic 
lesions. This could also provide a non-invasive technique for diagnosing women 
with active endometriosis. 
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Summary 
During this century, endometriosis has received much attention in the 
gynecologic literature. Various theories on the histo- and pathogenesis and the 
association with infertility have been proposed. When reading the older literature it 
is striking that several observations in recent literature were actually already 
described many years ago. 
In chapter 1 the literature on the histogenesis of endometriosis (coelomic 
metaplasia with or without induction versus the endometrial implantation theory), 
on possibly predisposing factors (luteinized unruptured follicle syndrome (LUF), 
immunologic alterations, amount of retrograde menstruation), and on the 
association with infertility is reviewed. The problems with regard to the diagnosis 
of endometriosis and the classification systems currently used are also discussed. 
The outline of this thesis is described at the end of this chapter. 
In chapter 2, an immunocytochemical comparison between endometriotic 
epithelial, endometrial epithelial and normal mesothelial cells is described. The 
epithelial markers BW 495/36 and HMFG-2 differentiate between endometriotic 
and endometrial epithelial cells versus normal mesothelial cells both in tissue 
sections as wel as in culture. A new monoclonal antibody (NEND-3) is also 
described which appears to be specific for active endometrial and endometriotic 
epithelial cells. Although these results are consistent with the endometrial 
implantation theory, they do not exclude the coelomic metaplasia theory, since 
coelomic metaplasia may result in a modified antigen expression. 
Chapter 3 describes a culture technique which gives an impression of the 
amount of refluxed endometrial epithelial cells during menstruation, which have 
retained the capacity to adhere and proliferate. In the majority of women these 
cells are present in PF during menstruation. A surprisingly large difference in cell 
number is observed between individuals, with a significantly higher number of 
these cells in women with "unexplained" infertility. This observation is consistent 
with the theory that an increased amount of retrograde menstruation can lead to 
infertility. 
In chapter 4 estradiol-17/J (E^ and progesterone (P) concentrations in 
peritoneal fluid (PF) samples obtained directly pre- and postovulatory are 
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compared, using daily ultrasound for ovulation detection. The pre- and 
postovulatory E2 concentrations show a wide overlap. A more pronounced 
distinction is obtained between pre- and postovulatory Ρ concentrations in PF, 
although some overlap remains. This is caused by those patients developing an 
cystic corpus haemorrhagicum shortly after ovulation. It is concluded that 
monitoring follicular growth (and eventually ovulation) by ultrasound is the method 
of choice for detecting LUF, although a slight risk remains that ovulation may be 
missed. 
In chapter 5 the same culture technique as described in chapter 3, is used to 
obtain an impression of the amount of refluxed endometrial epithelial cells after 
uterine-tubal flushing. The flush media contain varying amounts of endometrial 
epithelial cells capable of adherence and proliferation in vitro. Short incubation 
with 0.01 % methylene blue solution has a marked adverse effect on the growth 
capacity of these cells. Furthermore, the fact that in women with macroscopic 
endometriosis, a significantly larger volume of the standard amount of flush 
medium used (40 mL) can be recovered from the abdominal cavity, is a 
remarkable observation. This is consistent with the theory that women with 
endometriosis may have a hypotonia of the uterotubal junction. 
In chapter 6 the one- and two-step IRMA for measurement of CA 125 in both 
serum and PF are compared. For serum samples both techniques (one- and two-
step IRMA) give accurate results. For PF samples however, the results obtained 
with the one-step IRMA are invalid since at diluting the samples, the dilution 
curves do not follow the standard response curve. In contrast, serially diluted PF 
samples using the two-step IRMA reveal excellent parallelism with the standard 
response curve, resulting in much higher CA 125 concentrations in PF (range 
1800 - 5700 arb. U/mL) than previously described. The reason for this 
discrepancy between the one- and two-step IRMA for PF samples is unknown. 
In chapter 7 the two-step IRMA is used to determine PF CA 125 
concentrations and total amounts throughout the menstrual cycle in women with 
various infertility-related factors. Peritoneal fluid CA 125 concentration and total 
amount appears to be significantly lower during the luteal phase. Remarkably, 
retrograde menstruation (containing endometrial CA 125) has no significant 
influence on the total amount of CA 125 in PF. Furthermore, no significant 
difference in PF CA 125 concentratton and the total amount exists between 
women with and without endometriosis. An additional factor is proposed to 
explain elevated serum CA 125 concentrations in women with more extended 
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endometriosis. Peritoneal fluid contains high amounts of CA 125. The peritoneum 
normally functions as a barrier for molecules containing these CA 125 epitopes, 
resulting in a high ratio of PF to serum CA 125 concentration. When the 
peritoneum is impaired because of endometriotic lesions, this results in an higher 
release of CA 125 antigen into the circulation, which explains the elevated serum 
CA 125 concentrations. 
In chapter 8 the results of the studies outlined in the previous chapters are 
compared with the current theories on the histogenesis of endometriosis, and its 
association with retrograde menstruation and infertility. It is concluded that no 
convincing arguments have been described thus far which support either the 
endometrial implantation theory or the theory of coelomic metaplasia through 
induction. Furthermore, our results support the theory that the amount of 
retrograde menstruation is an important predisposing factor both with regard to 
the development of endometriosis and its frequent association with infertility. Many 
questions remain to be resolved however. 
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Samenvatting 
Endometriose staat al sedert ongeveer een eeuw in de belangstelling. Diverse 
theorieën met betrekking tot de histo- en Pathogenese, en de associatie met 
infertiliteit zijn geponeerd. Bij het lezen van de oudere literatuur valt op, dat vele 
bevindingen die in de recente literatuur worden beschreven, in werkelijkheid 
herhaalde constateringen zijn. 
In hoofdstuk 1 wordt een overzicht gegeven van de literatuur met betrekking 
tot de histogenèse van endometriose (mesotheelmetaplasie al dan niet door 
induktie versus de endometrium-implantatie theorie), mogelijk predisponerende 
factoren ("luteinized unruptured follicle syndrome" (LUF), immunologische 
afwijkingen, mate van retrograde menstruatie), en de associatie met infertiliteit. 
Ook de problemen m.b.t. het stellen van de diagnose endometriose en de daarbij 
tot nu toe gehanteerde klassificatie systemen worden besproken. De 
doelstellingen van de huidige studie worden aan het einde van het hoofdstuk 
nader uiteengezet. 
In hoofdstuk 2 wordt een immunocytochemische vergelijking beschreven 
tussen endometriose-epitheel met endometrium-epitheel en normaal mesotheel. 
Zowel op weefselcoupes als op gekweekte cellen differentieren de 
epitheelmarkers BW 495/36 en HMFG-2 tussen enerzijds endometriose- en 
endometrium-epitheelcellen, en anderzijds normaal mesotheel. Ook wordt een 
nieuw monoclonaal antilichaam beschreven (NEND-3) wat specifiek lijkt te zijn 
voor actieve endometrium- en endometriose-epitheelcellen. Alhoewel deze 
bevindingen passen bij de endometrium-implantatie theorie, kan de 
mesotheelmetaplasie nog immer niet worden uitgesloten, daar 
mesotheelmetaplasie gepaard kan gaan met een modificatie in antigeen-
expressie. 
Hoofdstuk 3 beschrijft een kweekmethode waarmee een indruk wordt 
verkregen van het aantal retrograad versleepte endometrium-epitheelcellen tijdens 
de menstruatie, die nog in staat zijn tot aanhechting en proliferatie. Het blijkt dat 
bij de meerderheid van vrouwen dergelijke cellen in peritoneal vloeistof aanwezig 
zijn tijdens de menstruatie. Opvallend is het grote interindividuele verschil in aantal 
prolifererende endometrium-epitheelcellen, waarbij bij vrouwen met "onbegrepen" 
infertiliteit een significant hoger aantal wordt geconstateerd. Deze laatste 
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bevinding is in overeenstemming met de theorie dat een vergrote mate van 
retrograde menstruatie kan leiden tot infertiliteit. 
In hoofdstuk 4 worden de oestradiol-17/? (E2) en progesteron (P) 
concentraties in direct pre- en post-ovulatoir verkregen peritoneale vloeistof met 
elkaar vergeleken, waarbij voor ovulatie-detectie gebruik werd gemaakt van 
dagelijkse echoscopie. Tussen de E2 concentraties pre- en postovulatoir blijkt een 
grote overlap te bestaan. Een duidelijker onderscheid bestaat er tussen de pre-
en post-ovulatoire Ρ concentraties in peritoneale vloeistof, zij het dat ook hierbij 
enige overlap bestaat. Deze wordt veroorzaakt door die gevallen, waarbij zich al 
snel postovulatoir een cysteus corpus haemorrhagicum ontwikkelt. De conclusie 
luidt dat het echoscopisch vervolgen van follikelgroei (en evt. ovulatie) de meest 
betrouwbare methode is om LUF te diagnostiseren, alhoewel ook hierbij een klein 
risico blijft bestaan dat ovulatie niet wordt gedetecteerd. 
In hoofdstuk 5 wordt dezelfde kweektechniek zoals beschreven in hoofdstuk 
3, gebruikt om een indruk te krijgen van het aantal retrograad versleepte 
endometrium-epitheelcellen na pertubatie. De flush media bevatten wisselende 
hoeveelheden endometrium-epitheelcellen met de mogelijkheid tot aanhechting en 
proliferatie in vitro. Een korte incubatie met 0,01% methyleenblauw oplossing heeft 
een duidelijke negatieve invloed op de groeicapaciteit van deze cellen. Een 
andere opvallende bevinding is de constatering dat bij vrouwen met 
macroscopisch zichtbare endometriose significant meer flush medium van een 
standaard gebruikte hoeveelheid (40 mL) uit de abdominaalholte kan worden 
opgezogen. Dit is in overeenstemming met de theorie dat bij vrouwen met 
endometriose een hypotonie bestaat t.p.v. de overgang uterus-tuba. 
In hoofdstuk 6 worden de een- en twee-staps "immunoradiometric assay" 
(IRMA) voor bepaling van CA 125 in serum en peritoneale vloeistof met elkaar 
vergeleken. Voor serum bepalingen geven beide technieken betrouwbare 
resultaten. Voor bepalingen in peritoneale vloeistof blijkt de een-staps methode 
niet betrouwbaar te zijn omdat de seriële verdunningscurve niet fraai parallel loopt 
met de zg. standaard respons curve. Daarentegen geeft de twee-staps methode 
wel een fraai parallel verlopende verdunningscurve met de standaard response 
curve, hetgeen resulteert in veel hogere CA 125 concentraties in peritoneale 
vloeistof dan tot nu toe beschreven. De reden voor deze discrepantie tussen de 
een- en twee-staps methode m.b.t. peritoneale vloeistof is vooralsnog niet 
bekend. 
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In hoofdstuk 7 wordt de 2-staps IRMA gebruikt, om de peritoneale vloeistof 
CA 125 concentratie te bepalen bij vrouwen met diverse met infertiliteit 
geassocieerde factoren tijdens verschillende fasen van de menstruele cyclus. Het 
blijkt dat zowel de CA 125 concentratie als totale hoeveelheid in peritoneale 
vloeistof significant lager is tijdens de luteale fase. Opvallend is dat retrograde 
menstruatie (met endometrium-CA 125) geen belangrijke bijdrage lijkt te leveren 
aan de hoeveelheid CA 125 in peritoneal vloeistof. Tevens wordt geen 
onderscheid in CA 125 concentratie en totale hoeveelheid geconstateerd tussen 
vrouwen met en zonder endometriose. Een alternatieve theorie wordt 
geïntroduceerd om verhoogde serum CA 125 concentraties bij vrouwen met 
ernstige endometriose te verklaren. Peritoneale vloeistof bevat grote hoeveelheden 
CA 125. Normaal functioneert het peritoneum als barriere met als gevolg een 
hoge ratio van peritoneale vloeistof / serum CA 125 concentraties. Bij 
beschadiging van het peritoneum tg.v. endometriose-lesies, ontstaat een 
verhoogde diffusie van CA 125 antigeen naar de circulatie, wat de verhoogde 
serum concentraties verklaart. 
In hoofdstuk 8 worden de gegevens van de studies zoals beschreven in de 
voorafgaande hoofdstukken vergeleken met de huidige theorieën aangaande de 
histogenèse van endometriose, alsmede de associatie met retrograde menstruatie 
en infertiliteit. De conclusie luidt dat er nog geen overtuigende argumenten zijn 
beschreven, die alleen pleiten voor de endometrium-implantatie theorie of de 
mesotheelmetaplasie door inductie theorie. Onze resultaten stemmen overeen met 
de opvatting dat de mate van retrograde menstruatie een belangrijke 
predisponerende factor vormt zowel voor het ontstaan van endometriose, als met 
de daarmee vaak geassocieerde infertiliteit. Er resteren echter nog vele vragen. 
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proefschrift; 
Dr. Ton Hanselaar voor de prettige manier van samenwerken met de afdeling 
Pathologische Anatomie (hoofd: Prof. Dr. G. Vooys); 
Drs. Ad Theeuwes en Drs. Anja Koster van de Medisch Statistische Afdeling 
(hoofd: Drs. W. Doesburg), voor de statistische bewerkingen en hulp bij de 
interpretatie daarvan; 
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Conny Vader voor haar hulp bij het op het juiste moment plannen van de 
laparoscopieën; 
De collegae gynaecologen en arts-assistenten, alsmede het OK-personeel van 
het St. Radboud ziekenhuis voor hun hulp bij het verzamelen van het materiaal; 
De collegae gynaecologen en arts-assistenten van het Bosch Medicentrum 
(lokatie Groot Ziekengasthuis) die mij dit jaar volop de ruimte hebben gegeven 
om tot een afronding van dit proefschrift te komen; 
Mia de Groot, Monica de Kerf-Klessens, Truus Gommans, Henriette Wijnen, en 
Monique Kaanders voor hun gewaardeerde secretariële ondersteuning; 
Drs. Dave Iles en Drs. Robert Thijssen voor hun bijdrage in de taalkundige 
kwaliteit van dit proefschrift; 
Margot Berkmans die de fraaie omslag ontwierp; 
Mijn ouders die de eerste aanzet gaven; 
Marian, Sander, Elmar, en Marloes aan wie ik de meeste dank verschuldigd 
ben. 
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Curriculum vitae 
De schrijver van dit proefschrift werd op 23 augustus 1957 in Tilburg geboren. 
Hij behaalde in 1975 het VWO-B diploma aan het Paulus Lyceum te Tilburg. Hij 
studeerde 1 jaar scheikunde aan de Katholieke Universiteit te Nijmegen wegens 
aanvankelijke uitloting voor de studie medicijnen. Vanaf 1976 studeerde hij 
medicijnen aan de Katholieke Universiteit in Nijmegen en behaalde het 
artsexamen op 20 mei 1983. In 1983 verrichtte hij onder leiding van Dr. J.M.J. 
Dony en Dr. E. Everhardt een wetenschappelijke stage naar de invloed van 
verschillende NaHCCVconcentraties op zowel spermatozoa als cervixslijm. 
Van september 1983 tot oktober 1984 was hij als arts-assistent gynaecologie / 
verloskunde werkzaam in het Militair Hospitaal "Dr. A. Mathijssen" ter vervulling 
van zijn militaire dienstplicht. Van november 1984 tot januari 1986 werkte hij als 
arts-onderzoeker in het Academisch Ziekenhuis Rotterdam "Dijkzigt", waarbij hij 
onder leiding van Prof. Dr. J.W. Wladimiroff participeerde in een 
onderzoeksproject gericht op cyclusafwijkingen bij "onbegrepen" infertiliteit en 
endometriose. 
Vanaf januari 1986 was hij werkzaam als arts-assistent gynaecologie / 
verloskunde in het St. Radboud Ziekenhuis te Nijmegen alwaar de opleiding tot 
gynaecoloog werd aangevangen in september 1986 (opleiders: Prof. Dr. T.K.A.B. 
Eskes en Prof. Dr. R. Rolland). De opleiding werd in januari 1990 voortgezet in 
het Bosch Medicentrum (lokatie Groot Ziekengasthuis) te 's-Hertogenbosch 
(opleider: Dr. R. de Boer). Op 1 september 1991 werd hij ingeschreven in het 
specialisten register. Vanaf die datum is hij gevestigd als gynaecoloog, 
vooralsnog op part-time basis, in het Bosch Medicentrum (lokatie Groot 
Ziekengasthuis). De resterende tijd is hij werkzaam in het St. Radboud 
Ziekenhuis, waarbij hij zich toelegt op de oncologische gynaecologie. 
Hij is gehuwd met Marian de Kort en is vader van Sander, Elmar, en Marloes. 
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Stellingen 
behorende bij het proefschrift 
"Endometriosis and retrograde menstruation" 
1. De uitspraak van Ridley (1968): "The history of endometriosis is one of the 
most interesting stories in medicine", zou anno 1991 gewijzigd kunnen 
worden in: "The interesting history of endometriosis in one of the most 
confusing stories in medicine". 
2. "It is of use from time to time to take stock, so to speak, of our knowledge 
of a particular disease to see exactly where we stand in regard to it, to 
inquire to what conclusions the accumulated facts seem to point and to 
ascertain in what direction we may look for fruitfull investigation into the 
future." (Sir William Osier, 1885) 
3. Een wetenschappelijke basis voor het behandelen van lichte graden van 
endometriose bij asymptomatische, infertiele vrouwen ontbreekt. 
4. Ter detectie van LUF-cycli is echoscopische monitoring van de follikel-groei 
te verkiezen boven oestradral-17/9 en progesteron bepalingen in peritoneale 
vloeistof. (dit proefschrift) 
5. Het aantal retrograad versleepte endometrium-epitheelcellen tijdens de 
menstruatie, met de capaciteit tot aanhechting en proliferatie in vitro, vertoont 
een grote interindividuele spreiding. (dit proefschrift) 
6. De nadelen van het gebruik van methyleenblauw bij laparoscopische 
pertubatie (toxisch voor spermatozoa / ovum / pre-embryo) moeten worden 
afgewogen tegen het eventuele voordeel dat methyleenblauw ook toxisch is 
voor tijdens deze ingreep retrograad versleepte endometrium-epitheelcellen. 
(dit proefschrift) 
7. Bepaling van CA 125 in peritoneale vloeistof m.b.v. de commercieel 
beschikbare 1-staps immunoradiometric assay, ontwikkeld voor bepaling in 
serum, is onbetrouwbaar en derhalve ongeschikt. (dit proefschrift) 
8. Ook met handschoenen aan blijft een bekken-toucher "natte vingerwerk". 
Nijmegen, 11 oktober 1991 R.F.P.M. Kruitwagen 



